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Perinatal inflammation is associated with an increased risk of brain injury and
neurodevelopmental impairment in preterm infants but the immune mediators
driving this association are not well understood. This PhD thesis seeks to
further characterise the inflammatory response associated with preterm birth,
describe the relationship between perinatal inflammation and white matter
development and explore the effect of specific inflammation-associated
proteins on the development of human cortical neurons derived from induced
pluripotent stem cells (iPSCs).
In the first study, I investigated the inflammatory profile at birth in 55 very
preterm infants, compared to 59 term-born controls and then used this profile
to predict exposure to intrauterine inflammation in the preterm group. Preterm
infants had a distinct pro-inflammatory profile in umbilical cord blood at
delivery when compared to term-born controls and IL-8 was found to be the
strongest predictor of intrauterine inflammation.
In the second study, I investigated the association between specific
inflammation-associated proteins and white matter microstructure in 71 very
preterm infants using structural MRI and diffusion-weighted imaging of the
brain. Elevated IL-8 in the first week of life was associated with white matter
dysmaturation at term-equivalent age.
Following this discovery, I investigated the effect of IL-8 on the maturation
and morphology of iPSC-derived cortical neurons and found that exposure
was associated with impaired neurite outgrowth.
This thesis provides further evidence to support the role of inflammation in
the aetiology of preterm brain injury and suggests that IL-8 dysregulation may
link systemic inflammation with atypical cortical development and white
matter disease in preterm infants.
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II. Lay Summary 
Preterm birth (before 37 weeks of gestation) affects approximately 11% of 
births globally each year. Some babies who are born too soon can encounter 
problems with learning, thinking and behaviour as they grow up due to 
altered brain development. We know that infection or inflammation around 
the time of birth can increase the risk of developmental problems but 
because our immune system responses to infection are complex, the specific 
mediators driving this association are not well understood.  
This thesis presents three studies which characterise the inflammatory profile 
associated with preterm birth and the role of specific immune proteins on 
brain development.  
In the first study I found that preterm infants have higher levels of pro-
inflammatory proteins in their umbilical cord blood at delivery when compared 
to healthy term-born infants. I also found that a protein generated by the 
immune system in response to infection, known as interleukin-8 (IL-8), can 
predict which babies were exposed to infection before they were born.  
In the second study I found that IL-8 measured from blood taken in the first 
week of life was associated with altered development of the major 
information highways of the brain in preterm infants who had a brain MRI 
performed around their due date.  
In the final study I used human stem cells to generate neurons (specialised 
nerve cells which transmit and receive information from other nerve cells) 
and found that when they were exposed to IL-8 during early development, 
they did not grow as well. 
These studies show that the immune system is involved in altered brain 
development in preterm infants and suggest that therapies to reduce 
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1.1 The global burden of preterm birth 
 
1.1.1 Epidemiology 
Preterm birth is defined as live birth before 37 completed weeks of pregnancy 
(WHO 1977). This can be classified as extremely preterm (<28 weeks), very 
preterm (28-32 weeks) and moderate to late preterm (32-37 weeks) 
(Blencowe et al. 2012). In 2014, approximately 14.84 million babies were 
delivered preterm worldwide, indicating a global preterm birth rate of 10.6% 
(Chawanpaiboon et al. 2019). Complications related to preterm birth are the 
leading cause of mortality in children under 5 years (Blencowe et al. 2013) 
and are responsible for 35% of deaths in the neonatal period (UN 2019).  
Preterm birth can be classified into deliveries that were indicated due to 
maternal, fetal or placental complications and those that followed 
spontaneous preterm labour. Many risk factors are known to be associated 
with preterm birth including maternal demographics, assisted reproductive 
technology, pregnancy complications, previous preterm birth and 
psychosocial influences but the cause is not always fully understood 
(Goldenberg et al. 2008; Barros et al. 2015; Ferrero et al. 2016). 
 
1.1.2 Consequences of preterm birth 
Whilst there have been significant advances in survival at the lowest 
gestational ages, there have not been significant improvements in the 
prevalence of major neonatal morbidities including bronchopulmonary 
dysplasia, necrotising enterocolitis, sepsis and brain injury (Costeloe et al. 
2012; Fanaroff et al. 2007; Shah et al. 2012; Chen et al. 2016). Cohort 
studies have shown that amongst infants born very preterm there is a 19-
35% incidence of moderate to severe disability in early childhood (Moore et 
al. 2012; Serenius et al. 2013; Pierrat et al. 2017; Rysavy et al. 2015; Draper 
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et al. 2019). This includes motor problems, cognitive impairment and sensory 
deficits (Johnson and Marlow 2017). 
 
Whilst cerebral palsy (CP) affects 5-10% of survivors the rates of motor 
impairment without CP (balance, co-ordination, fine motor skills) remain 
significant, with very preterm infants scoring 0.57-0.88 SD below term-born 
peers in standardised tests of motor development in childhood (Spittle et al. 
2018; Reid et al. 2016; Bolk et al. 2018; de Kieviet et al. 2009).   
 
Preterm infants are at increased risk of neurocognitive impairment including  
lower IQ, executive dysfunction, and difficulties with working memory and 
language processing (Anderson 2014; Allotey et al. 2018; Brydges et al. 
2018; Twilhaar et al. 2018; van Noort-van der Spek, Franken, and Weisglas-
Kuperus 2012; Mulder et al. 2009). This has a pervasive effect on 
educational outcomes and academic performance (Twilhaar et al. 2018; 
Pettinger et al. 2020).  
 
Preterm born children also exhibit a behavioural phenotype characterised by 
inattention, anxiety, peer problems and social withdrawal (Johnson and 
Marlow 2011; Ritchie, Bora, and Woodward 2015; Burnett et al. 2019). 
Neuropsychiatric disorders such as autistic spectrum disorder (ASD) and 
attention deficit hyperactivity disorder (ADHD) are more prevalent (Burnett et 
al. 2011; Agrawal et al. 2018; Franz et al. 2018; Montagna et al. 2020) and 
there is an increased risk of hospitalisation for psychosis, bipolar disorder or 
depression in adulthood (Nosarti et al. 2012). 
 
Preterm birth has long-term consequences on adult functioning (Breeman et 
al. 2015). Cognitive deficits and attention problems persist into adulthood 
(Linsell et al. 2018; Breeman et al. 2016) and are associated with lower 
levels of education, employment, income and self-esteem (Saigal et al. 2016; 
Bilgin, Mendonca, and Wolke 2018). Preterm born adults have higher rates of 
internalising and avoidant personality problems than term born peers (Pyhälä 
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et al. 2017) and are less likely to form partner relationships or have children 
(Mendonça, Bilgin, and Wolke 2019). 
 
Preterm birth is a global public health problem associated with a range of 
adverse lifecourse outcomes, significant health and education costs to 
society and a legacy that continues to impact future generations. There is an 
urgent need for effective treatments to reduce the risk of impairment. Further 
knowledge of the ontogeny and neurobiology underlying the brain 
dysmaturation associated with preterm birth is required to identify potential 
therapeutic targets. 
 
1.2 Preterm brain injury 
1.2.1 Overview of brain development 
Neurodevelopment in utero represents a period of rapid brain growth 
(Andescavage et al. 2017; O’Rahilly and Muller 2006) with many complex 
dynamic processes vulnerable to injury associated with preterm birth, 
including neurogenesis, glial development and myelination. Key 
neurodevelopmental processes in humans are outlined in Figure 1-1. 
 
 
Figure 1-1 Key neurodevelopmental processes in humans. 





Neurogenesis begins shortly after neural tube formation at post-conceptional 
week (PCW) 4 (Bayer and Altman 2007).The wall of the neural tube contains 
a layer of neuroepithelial cells called the ventricular zone (VZ), where 
symmetrical division of neural progenitor cells (NPCs) expands the progenitor 
pool. The earliest neurons of the cortical plate emerge at PCW 7. The 
subventricular zone (SVZ) is established above the VZ and contributes to the 
generation of all excitatory projection neurons and glia via radial glia (RG) 
and transit amplifying intermediate progenitor cells (IPCs) (Kriegstein and 
Alvarez-Buylla 2009; Taverna, Gotz, and Huttner 2014; Silbereis et al. 2016).  
 
1.2.1.2 Neuronal migration 
Once formed neurons migrate from their site of origin in proliferative zones to 
the developing six-layered neocortex with the deepest layer populated first 
(Marin-Padilla 2014). By 24 weeks, the cerebral cortex has been populated 
by the full complement of glutamatergic excitatory projection neurons, whilst 
tangential migration of gamma-aminobutyric acid (GABA)-expressing 
interneurons from the ganglionic eminences occurs later, reaching peak 
density at term (Xu et al. 2011; Hansen et al. 2013; Arshad et al. 2016).  
 
1.2.1.3 Organisation 
On arrival at the cortical plate neurons continue to mature with a protracted 
period of neurite outgrowth, dendritic arborisation and synaptogenesis which 
continues into early childhood. The earliest synapses are formed in the 
subplate zone, which functions as a site of synaptic contact for ascending 
axonal afferents and provides axonal path guidance in cortical circuit 
formation (Kostovic and Judas 2010; Haynes et al. 2005; Kanold 2009). 
Development of the subplate peaks between PCW 24 and 32, a time of 
critical vulnerability for the preterm infant with injury likely to impact emerging 




Astrocytes and oligodendrocyte precursors are generated from RG cells 
following neurogenesis (Howard et al. 2008), from PCW 30 to term. 
Astrocytes are multifaceted cells with important roles in development and 
homeostasis, providing nutritional, metabolic and structural support (Reemst 
et al. 2016).  
 
Microglia originate from erythromyeloid precursor cells and infiltrate the CNS 
from PCW 4 (Lenz and Nelson 2018). Microglia are the resident 
macrophages of the brain involved in innate immunity and the maintenance 
of physiological homeostasis (Menassa and Gomez-Nicola 2018). Recently 
developed tools have demonstrated an array of microglial phenotypes with 
different context specific roles in neurodevelopment (Bennett et al. 2016). 
The major influx occurs at around PCW 16 but it is not until PCW 35 that they 
become widely distributed. Microglia are abundant in white matter in 
association with developing tracts (Verney et al. 2010; Billiards et al. 2006) 
and contribute to axonal development, oligodendrocyte maturation and 
myelination (Reemst et al. 2016; Hammond, Robinton, and Stevens 2018; 
Hagemeyer et al. 2017; Frost and Schafer 2016; Matsui and Mori 2018). If 
activated in response to danger signals, both astrocytes and microglia can 
release damaging pro-inflammatory cytokines, free radicals and glutamate, 
which may disturb key maturational events (Liddelow et al. 2017; Matsui and 
Mori 2018; Rothhammer and Quintana 2015).  
  
1.2.1.5 Myelination 
The process of myelination begins with oligodendrocyte progenitor cell (OPC) 
proliferation and differentiation. OPC’s transition into pre-oligodendrocytes 
(pre-OL) with ongoing proliferative capacity and then post-mitotic immature 





Figure 1-2. Oligodendrocyte maturation. 
 
This transition results in a predominance of pre-oligodendrocytes in cerebral 
white matter from 24 PCW (Back et al. 2002). The initial deposition of myelin 
around axons progresses to form a more compacted myelin sheath. Whilst 
this process begins during the third trimester, mature myelin-producing 
oligodendrocytes are not abundant in white matter until after term (Semple et 
al. 2013).   
 
Perturbation of these key developmental processes due to environmental 
exposures associated with preterm birth has multiple adverse consequences 
for the developing brain. 
 
1.2.2 The encephalopathy of prematurity 
Preterm brain injury is multifactorial and results in a combination of 
destructive lesions and developmental disturbances collectively described as 
the encephalopathy of prematurity (Volpe 2009).  
 
Immature vasculature, cardiovascular instability and limited cerebral 
autoregulation predisposes to intraventricular and cerebellar haemorrhage. 
Intraventricular haemorrhage (IVH) typically occurs in the first 72 hours of life 
with bleeding into the germinal matrix followed by extension into the 
ventricular system. This can be categorised into four grades depending on 
site and severity (Papile et al. 1978) with grade IV representing a destructive 
parenchymal lesion resulting from haemorrhagic venous infarction (Bassan et 
al. 2006). Cerebellar haemorrhage ranges from mild punctate lesions to more 
extensive bilateral haemorrhages. The incidence of intraventricular and 
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cerebellar haemorrhage increases with the degree of prematurity and they 
often co-exist (Fumagalli et al. 2015; Limperopoulos, du Plessis, and Volpe 
2018). 
 
Preterm infants are at risk of cerebral hypoxia-ischaemia and 
infection/inflammation both in utero and postnatally during neonatal intensive 
care due to immature organ systems and the complications of prematurity. 
These processes trigger pathways of glutamate excitotoxicity, free radical 
injury and neuroinflammation. Activation of microglia and astrocytes results in 
the generation of pro-inflammatory cytokines and chemokines leading to 
altered blood brain barrier integrity, recruitment of peripheral immune cells 
and cellular injury (Baburamani et al. 2014; Back 2017).  
Pre-oligodendrocytes, subplate neurons and developing axons are 
particularly susceptible to injury. This results in abnormal brain growth, white 
matter injury, impaired cortical and thalamic development, microstructural 
dysmaturation and altered connectivity of developing neural networks (Volpe 
2019). 
 
White matter is the predominant site of brain injury in the preterm population 
due to the vulnerability of pre-oligodendrocytes to injury and cell death (van 
Tilborg et al. 2018; Volpe 2019; Buser et al. 2012). Following insult, the 
population of pre-oligodendrocytes are replenished but they fail to 
differentiate. Arrested oligodendrocyte maturation results in hypomyelination 
and a spectrum of white matter injury, from diffuse axonal injury with gliosis 
to localised necrosis in cystic periventricular leukomalacia (PVL). However, 
white matter injury is also associated with grey matter neuronal loss and 
gliosis affecting the cortex, thalamus and basal ganglia (Pierson et al. 2007; 
Ligam et al. 2009). Damage to developing white matter axons and subplate 
neurons impairs cortical dendritic development and synaptogenesis with 
adverse consequences for developing neural networks (Sarnat et al. 2015). 
Furthermore, impaired interactions between the cortex and cerebellum 
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alongside exposure of the vulnerable proliferating external granule layer to 
damage mediators in the CSF also results in cerebellar growth failure.  
 
1.3 Imaging the developing brain 
1.3.1 Magnetic resonance imaging 
Magnetic resonance imaging (MRI) is a safe, non-invasive technique which 
allows a detailed assessment of brain anatomy using structural and diffusion 
weighted imaging. Technical developments and processing pipelines 
optimised for fetal and neonatal imaging have generated a vast array of 
powerful tools to study the developing brain (Pecheva et al. 2018; Dubois et 
al. 2020; Hinojosa-Rodríguez et al. 2017). Most scans are now performed 
using a 1.5 or 3 Tesla scanner. Signal-to-noise ratio has been improved 
through the use of a close fitting neonatal head coil, protocols have been 
developed to optimise image resolution in the neonatal brain and several 
groups have demonstrated success in obtaining high quality images without 
the need for sedation.  
 
1.3.2 Conventional structural MRI 
T1-weighted (T1w) and T2-weighted (T2w) imaging provides contrast 
between tissues at millimetre resolution and can detect brain lesions 
associated with preterm birth at term-equivalent age. Ths includes 
recognised pathologies frequently identified on cranial ultrasound such as 
IVH, haemorrhagic parenchymal infarction and cystic PVL but also more 
subtle features such as diffuse white matter abnormalities and cerebellar 
haemorrhage.  
 
Diffuse white matter abnormalities include diffuse excessive high signal 
intensity (DEHSI) and punctate white matter lesions (PWML) (Counsell, 
Allsop, and Harrison 2003; Bassi, Chew, and Merchant 2011). DEHSI is 
present in up to 80% of very preterm infants at term-equivalent age (Dyet et 
al. 2006), whilst PWML are observed in 10-24% of very preterm infants, 
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predominantly seen in the regions of the centrum semiovale, corona radiata 
and arcuate fasciculi (Neubauer et al. 2017; Tusor et al. 2017). PWML have 
high signal intensity on T1-weighted imaging and frequently low intensity on 
T2-weighted imaging suggesting an underlying ischaemic pathology or 
increased cellularity (Rutherford et al. 2010). Figure 1-3 shows T2-weighted 
images of common neonatal pathologies seen on conventional structural MRI 
in preterm infants at term-equivalent age. 
 
 
Figure 1-3. Transverse T2-weighted images at term-equivalent age showing (A) punctate 
white matter lesions, (B) periventricular leukomalacia, and (C) haemorrhagic parenchymal 
infarction.  
Adapted from (Plaisier et al. 2014) with permission. 
 
Severe destructive lesions such as cystic PVL and haemorrhagic 
parenchymal infarction are associated with major disability such as CP, whilst 
PWML and cerebellar lesions are more often associated with cognitive and 
behavioural problems (Hintz et al. 2018; Villamor-Martinez, Fumagalli, et al. 
2019; Hortensius et al. 2018; Arulkumaran et al. 2020; Woodward et al. 2012; 
Mukerji, Shah, and Shah 2015; Guo et al. 2017).  
 
However, the prognostic ability of structural MRI is modest. A recent study of 
504 very preterm infants showed that 3T MRI at term-equivalent age with no 
focal lesion has a sensitivity of 45% (95% CI, 40-50%), and a specificity of 
61% (95% CI, 51%-71%) for normal neurodevelopmental outcome 





1.3.3 Quantitative structural MRI 
Quantitative techniques can be applied to structural images to enable brain 
tissue segmentation and anatomical parcellation of regions of interest. 
Computational approaches have shown that preterm infants have significant 
abnormalities in regional brain growth and development when compared to 
term-born controls.  
 
Morphometric studies have shown that preterm infants have reduced total 
and regional brain volumes affecting the white matter, thalamus, basal 
ganglia, hippocampus, cortex and cerebellum (Padilla et al. 2014; 
Makropoulos et al. 2016; Inder et al. 2005; Boardman et al. 2006; Thompson 
et al. 2007; Strahle et al. 2019).  
 
Studies have also demonstrated altered cortical folding and reduced cortical 
surface area in preterm infants when compared to term-born controls 
(Shimony et al. 2016; Engelhardt et al. 2015). The fastest growing brain 
tissues between preterm birth and term-equivalent age are the cortical gray 
matter and cerebellum and longitudinal measurements are predictive of 
cognitive and motor outcomes in early childhood (Rathbone et al. 2011; 
Moeskops et al. 2017; Gui et al. 2019). 
 
These imaging signatures of neuronal loss, axonal disturbance and altered 
gyrification are present at term-equivalent age but also persist into childhood 
and adolescence (Zhang et al. 2015; Nosarti et al. 2002; Papini et al. 2020). 
 
More advanced quantitative MRI techniques to assess brain microstructure 
provide an early indicator of cell damage and have further enhanced our 
understanding of the neurobiology underlying these imaging signatures. 
 
1.3.4 Diffusion tensor imaging 
Diffusion tensor imaging (DTI) is an advanced MRI technique which enables 
assessment of microstructural characteristics through the measurement of 
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water diffusion in brain tissue. DTI measures the magnitude and direction of 
water molecule diffusion along multiple axes to obtain a mathematical 
representation of water movement within individual voxels of an image 
(Basser, Mattiello, and LeBihan 1994). Measurements acquired from multiple 
directions can be used to generate a tensor matrix which can be analysed to 
produce three eigenvalues (𝜆1, 𝜆 2, 𝜆 3) and three eigenvectors (ε1, ε2, ε3). 
The primary eigenvalue (𝜆1) represents water diffusivity along the principal 
axis (ε1), known as axial diffusivity (AD). Radial diffusivity (RD) is calculated 
from the average of the second and third eigenvalues (𝜆 2, 𝜆 3) and describes 
the average water diffusion perpendicular to the principal axis. Mean 
diffusivity (MD) is the average of all 3 eigenvalues and describes the 
magnitude of water diffusion within a voxel. 
Fractional anisotropy (FA), a measurement that quantifies the shape of the 
diffusion ellipsoid, is a scalar taking values from 0 to 1 which represents the 
degree of directional variation of water diffusion. In the CSF, water diffusion 
is unrestricted or isotropic with eigenvalues equivalent in all directions (FA = 
0), creating a spherical ellipsoid. Within brain tissue, water diffusion is 
directionally dependent due to hindrance by cellular membranes with 
diffusion anisotropy closer to 1 (FA ~ 0.5 to 0.8)  (Pierpaoli and Basser 1996; 
Beaulieu 2002).  
 
 
Figure 1-4. Isotropic and anisotropic water diffusion in the brain. 
In the white matter of the corpus callosum (shown in red), water diffusion occurs 
preferentially along axonal tracts, known as anisotropic diffusion (b). In the CSF (shown in 
green), water diffusion is isotropic (c)  




FA is sensitive to microstructural changes including axonal size and density, 
AD is thought to describe axonal integrity whilst RD provides information 
about oligodendrocyte ensheathment of axons and later myelination (Pandit 
et al. 2013). Representative images of FA, MD, AD and RD in the neonatal 
brain are shown in Figure 1-5. 
 
 
Figure 1-5. Coronal and axial slices demonstrating water diffusion tensor maps in the 
neonatal brain. 
Reproduced with permission from (Dean et al. 2017). 
 
The quantitative information from DTI has been used to describe the 
characteristic microstructural changes associated with early brain 
development. White matter maturation is associated with increasing FA and 
reductions in MD and RD, reflecting microstructural changes associated with 
axonal packing, membrane proliferation and myelination (Huppi et al. 1998; 






Figure 1-6. The relationships between maturational processes and water diffusion metrics in 
white matter. 
Reproduced from (Ouyang et al. 2019) with permission. 
 
 
In the cortex, maturation is characterised by decreasing FA and MD reflecting 
dendritic arborisation and neurite growth (Batalle et al. 2019; Ouyang et al. 
2019; Bouyssi-Kobar et al. 2018).  
 
By term-equivalent age, the preterm brain is structurally different from that of 
healthy term-born controls, characterised by lower FA and higher MD in white 
matter (Anjari et al. 2007; Rose et al. 2008). This is exacerbated by exposure 
to cumulative risk factors such as fetal growth restriction, bronchopulmonary 
dysplasia and necrotising enterocolitis, and is associated with 
neurodevelopmental performance in early childhood (Counsell et al. 2008; 
van Kooij et al. 2012; Ullman et al. 2015; Barnett et al. 2018). 
 
Whilst water diffusion parameters demonstrate microstructural alterations, 
the DTI model lacks tissue specificity and can be inaccurate when there are 
multiple fibre populations or when fibres cross within an individual voxel 
(Tournier, Mori, and Leemans 2011). High angular resolution diffusion 
imaging (HARDI) data can be used to apply more complex biophysical 
models, such as neurite density and orientation dispersion index (NODDI) to 
describe microstructural complexity characterised by the degree of diffusion 
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restriction within different compartments (Zhang, Schneider, et al. 2012). 
NODDI models the intracellular, extracellular and CSF fractions to calculate a 
neurite density index (NDI) and an orientation dispersion index (ODI) which 
describes both cellular density and the geometrical organisation of neurites.  
Representative images of the volume fraction of the intracellular 
compartment (vIC), volume fraction of the isotropic diffusion compartment 
(vISO) and ODI in the neonatal brain are shown in Figure 1-7. 
 
 
Figure 1-7. Coronal and axial slices demonstrating NODDI maps in the neonatal brain. 
Reproduced with permission from (Dean et al. 2017). 
 
Perinatal maturation is characterised by increasing NDI in white matter and 
increasing ODI in grey matter and both are affected by prematurity (Kunz et 
al. 2014a; Eaton-Rosen et al. 2015; Batalle et al. 2019).  
 
The integration of DTI scalars and NODDI metrics in morphometric similarity 
networks (Galdi et al. 2020; Fenchel et al. 2020) and histogram based 
analyses (Blesa et al. 2020) have recently been optimised for studying the 
neonatal brain. 
Peak width of skeletonised mean diffusivity (PSMD) is a method for 
histogram-based calculation of MD distribution across the entire white matter 
skeleton, which provides a single measure of generalised white matter 
microstructure. PSMD has been used to describe white matter disease 
burden in the context of multiple sclerosis and cerebrovascular disease and 




(Baykara et al. 2016; Deary et al. 2019; Wei et al. 2019; Low et al. 2020). 
The histogram model was recently extended to include 5 other histogram-
based metrics derived from DTI and NODDI to evaluate their accuracy as 
biomarkers of white matter dysconnectivity associated with preterm birth. 
Whilst there were group differences in peak width of skeletonised axial and 
radial diffusivities (PSAD, PSRD) and orientation dispersion index (PSODI) in 
preterm infants when compared to term-born controls, peak width of 
skeletonised neurite density index (PSNDI) and PSMD were found to be the 
best classifiers of gestational age at birth with an accuracy of 81±10% and 
77±9% respectively (Blesa et al. 2020). As sensitive markers of generalised 
white matter connectivity in the developing brain, PSMD and PSNDI offer 
promising tools to investigate the effect of perinatal exposures on developing 
microstructure. The imaging pipeline for the generation of PSMD and PSNDI 
is described in Chapter 2, section 2.5.5.  
 
1.4 The role of inflammation in preterm brain injury 
1.4.1 The innate immune response 
Inflammation is a complex response to infection or tissue injury involving the 
interaction between cells and a large range of soluble factors. Pattern 
recognition receptors (PRRs) on mast cells and macrophages recognise 
pathogen associated molecular patterns (PAMPs) from invading microbes or 
damage-associated molecular patterns (DAMPs) from damaged cells to 
generate a variety of inflammatory mediators including cytokines and 
chemokines alongside activation of the complement cascade. Pro-
inflammatory cytokines Interleukin (IL)-1b, IL-6 and Tumor necrosis factor-a 
(TNF-a) elicit an acute phase response co-ordinated by the liver through the 
release of regulatory proteins such as C-reactive protein (CRP). 
Chemokines including IL-8, Monocyte chemotactic protein-1 (MCP-1), and 
Regulated upon activation, normal T cell expressed and secreted (RANTES), 
facilitate the recruitment of neutrophils to the site of infection or injury through 
chemotaxis and endothelial activation (Turner et al. 2014). On arrival, 
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neutrophils become activated and attempt to clear invading pathogens by 
phagocytosis or toxic degranulation.  
The complement system is an important branch of the innate immune system 
comprising multiple recognition molecules which when activated, result in the 
recruitment of a cascade of enzymes to produce potent anaphylatoxins that 
enhance phagocytosis and the lytic membrane attack complex (MAC).  
Ordinarily, the combined mechanisms of the innate immune response 
facilitate pathogen clearance and tissue repair but when dysregulated can 
result in an amplified response and tissue damage (Medzhitov 2008; Nathan 
2002). 
 
1.4.2 Chorioamnionitis and the fetal inflammatory response 
 
One example of perinatal immune activation in preterm infants is histologic 
chorioamnionitis (HCA). HCA describes intrauterine inflammation, 
characterised by the infiltration of neutrophils into maternal or fetal placental 
structures (Redline et al. 2003). HCA complicates 40-70% of preterm births 
with a higher incidence associated with prolonged rupture of membranes 
(PROM), spontaneous preterm labour and lower gestational age (Goldenberg 
et al. 2008; Stoll et al. 2010). Whilst intraamniotic inflammation in the 
absence of infection can occur (Romero et al. 2015), the most frequent cause 
is ascending invasion by common microbes of the lower genital tract such as 
Ureaplasma, Group B Streptococcus, Escherichia coli and Fusobacteria 
(DiGiulio et al. 2008; Yoneda et al. 2016; Leviton et al. 2010). The amniotic 
sac is composed of the transformed maternal endometrium of pregnancy (the 
decidua) in direct contact with fetal components. In response to a 
chemotactic gradient, neutrophils migrate from the maternal capillaries of the 
decidua into the fetal chorion and then amniotic membranes, termed 
chorioamnionitis. The fetal inflammatory response is characterised by 
inflammation involving the vessels of the chorionic plate, known as vasculitis, 
or the umbilical cord, termed funisitis. Acute funisitis begins as inflammation 
of the umbilical vein (phlebitis) followed by involvement of umbilical arteries 
(arteritis) in multiple foci which merge as inflammation becomes more 
1-17 
 
advanced. (Kim et al. 2015; Presicce et al. 2018). Figure 1-8 shows placental 





Figure 1-8. Placental anatomy in the context of intrauterine infection. 
Reproduced with permission from (Goldenberg, Hauth, and Andrews 2000), Copyright 
Massachusetts Medical Society. 
 
The most frequently used staging system classifies acute inflammatory 
placental lesions into maternal inflammatory responses and fetal 
inflammatory responses with high reproducibility (Redline et al. 2003). 
The severity of funisitis has been correlated with fetal plasma IL-6 (Kim et al. 
2001), which is a major mediator of the acute systemic inflammatory 
response. Fetal inflammatory response syndrome (FIRS) was initially defined 
as umbilical cord blood IL-6 >11ng/mL (Gomez et al. 1998; Gotsch et al. 
2007; Pacora et al. 2002) but subsequent studies have shown that the fetal 
inflammatory response is associated with alterations in a wide range of pro-




1.4.3 Neuroinflammation in the developing brain 
Activation of the systemic inflammatory response results in the generation of 
a complex network of immune mediators capable of initiating a 
neuroinflammatory response in the developing brain (Hagberg et al. 2015).  
Preterm birth is associated with a distinct CSF inflammatory profile 
(Boardman et al. 2018) and post-mortem studies show upregulated 
expression of several pro-inflammatory cytokines in the brains of infants with 
confirmed infection (Kadhim et al. 2001; Folkerth et al. 2004). Peripheral 
immune mediators may access the CNS due to altered blood brain barrier 
permeability (Stolp et al. 2005), or may act via receptors expressed in the 
circumventricular organs, choroid plexus and leptomeninges (Rivest 2003; 
Galea, Bechmann, and Perry 2007). However, activation of resident microglia 
plays a key role in the pathogenesis of CNS inflammation and brain injury 
(Mallard, Tremblay, and Vexler 2019). 
 
Microglia express a range of PRRs which can become activated by damaged 
tissues, cytokines, bacterial products or invading organisms (Kettenmann et 
al. 2011). Activated microglia secrete a range of soluble factors to propagate 
the immune response and undergo morphological changes to facilitate 
phagocytosis of dead cells and debris. The vast array of cytokines and 
chemokines produced promote microglial proliferation, induce pro-
inflammatory reactive astrocytes, and function as chemo-attractants for other 
circulating immune cells (Liddelow et al. 2017). Increased production of cell 
adhesion molecules facilitates migration and extracellular matrix proteinases, 
such as matrix metalloproteinases (MMPs) contribute to breakdown of the 
blood brain barrier. Pro-inflammatory cytokines and chemokines contribute to 
glutamate excitotoxicity and free radical injury when produced by microglia in 
excess, causing neuronal cell death, astrogliosis and pre-oligodendrocyte 
maturation arrest (Baburamani et al. 2014).  
 
Neuroinflammation can also activate the adaptive immune response, which 
may contribute to the pathogenesis of brain injury by shifting naïve helper T 
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(Th) cells patrolling the borders of the CNS towards a pro-inflammatory Th1 
differentiation and via inhibition of regulatory T cells (Leviton, Dammann, and 
Durum 2005; Vivier and Malissen 2005; Carroll 2004; Ellwardt et al. 2016; 
Nguyen, Julien, and Rivest 2002). CD3+ T cells and CD 20+ B cells have 
been observed in the post-mortem brains of preterm infants with white matter 
injury (Nazmi et al. 2018). 
 
Neuroinflammation results in injury to subplate neurons, migrating white 
matter axons and pre-oligodendrocytes during critical phases of white matter 
development and cortical plasticity with long-term adverse consequences on 
brain microstructure, connectivity and function. 
 
1.4.4 Outcomes following perinatal inflammation 
Preterm infants exposed to HCA in utero are at increased risk of developing 
neonatal complications, including respiratory distress syndrome (RDS), 
bronchopulmonary dysplasia (BPD), early-onset sepsis (EOS), necrotising 
enterocolitis (NEC) and retinopathy of prematurity (ROP) (Bose et al. 2011; 
Villamor-Martinez, Álvarez-Fuente, et al. 2019; Been et al. 2013; Villamor-
Martinez et al. 2018; Hofer et al. 2013; Ozalkaya et al. 2016; Otsubo et al. 
2017). 
HCA has also been associated with white matter injury (Anblagan et al. 
2016), cerebral palsy (Shatrov et al. 2010; Shi et al. 2017), 
neurodevelopmental impairment and autism spectrum disorder (Al-Haddad et 
al. 2019; Salas et al. 2013; Venkatesh et al. 2020). 
 
Similar associations have been observed between neonatal infection and 
neurocognitive performance in childhood (Stoll et al. 2004; Schlapbach et al. 
2011; Bassler et al. 2009; Pappas et al. 2014; Francis et al. 2019; Salas et al. 
2013; Bright et al. 2017), with repeated episodes of inflammation increasingly 
recognised to confer additive risks to the developing brain (O'Shea et al. 
2012; O'Shea et al. 2013; Hansen-Pupp et al. 2008; Kuban et al. 2014; 
Leviton et al. 2016; Yanni et al. 2017; Kuban et al. 2017; Barnett et al. 2018).  
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Fetal exposure to inflammation may influence innate and adaptive immune 
programming which may explain this multi-hit hypothesis (Sabic and Koenig 
2020). Whole blood transcriptomic analyses showed that 488 genes were 
differentially expressed in the context of HCA (Weitkamp et al. 2016), 
including microRNA 155 (miR-155), a known master regulator of immune 
responses (Mahesh and Biswas 2019). HCA has been associated with the 
upregulation of pro-inflammatory T helper cell subsets, such as Th17 cells 
(Rito et al. 2017) which can secrete IL-17 and may contribute to organ injury 
(Lawrence and Wynn 2018) and RNA sequencing of HCA exposed 
monocytes showed an altered responsiveness to subsequent inflammatory 
stimulation in vitro (de Jong et al. 2018; Bermick et al. 2019). Altered immune 
programming in utero may therefore contribute to an increased risk of 
subsequent infection and/or dysregulation of immune responses to future 
inflammatory exposures. 
 
Specific inflammatory mediators have been investigated as potential 
biomarkers of HCA and long-term outcomes. Higher levels of IL-1b, IL-6, IL-
8, IL-10, IFN-g and TNF-a in umbilical cord blood, postnatal blood, and CSF 
have been associated with the development of IVH and white matter injury 
after preterm birth (Duggan et al. 2001; Lu et al. 2016; Ellison et al. 2005; 
Leviton et al. 2018; Hansen-Pupp et al. 2005) whilst higher umbilical cord 
blood and postnatal blood levels of TNF-a, IL-8 and IL-18 have been 
associated with the development of CP (Hansen-Pupp et al. 2008; Yanni et 
al. 2017; Minagawa et al. 2002; Carlo et al. 2011). 
Elevated levels of IL-8, TNF-a, and ICAM-1 in the first month of life were 
associated with increased risk of executive dysfunction (Leviton et al. 2019) 
amongst preterm born children whilst higher circulating neurotrophins were 
associated with a reduced risk of cognitive impairment (Kuban et al. 2018).   
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1.5 Experimental models of preterm brain injury  
1.5.1 Animal models  
Experimental models of preterm brain injury in a range of different species 
have consistently shown that exposure to gram-negative endotoxin 
lipopolysaccharide (LPS) or systemic administration of IL-1b causes 
microglial activation and neuroinflammation with resulting grey and white 
matter damage (Boksa 2010; Kuypers et al. 2012; Favrais et al. 2011; 
Mallard, Tremblay, and Vexler 2019; Smith, Hagberg, et al. 2014; Dean et al. 
2011; Dieni et al. 2004).  
 
Whilst the underlying mechanisms linking microglial activation with brain 
dysmaturation are not well understood, several studies suggest that pro-
inflammatory cytokines are likely mediators of injury (Pang, Cai, and Rhodes 
2003; Nobuta et al. 2012; Bonestroo et al. 2015; Serdar et al. 2019).  
Activation of the innate immune system via toll-like receptors (TLR) 
(Lalancette-Hébert et al. 2017) also makes the developing brain more 
susceptible to future insults (Eklind et al. 2001). TLR activation leads to the 
production of pro-inflammatory cytokines IL-1b and TNF-a via the MyD88 
pathway. Inhibition of downstream MyD88 pathways which reduce NF-𝜅B 
and JNK signalling have been shown to reduce microglial activation, 
neuroinflammation and cellular injury (Wang et al. 2009; Yang et al. 2013). 
 
Although animal models can recapitulate some of the features of the 
encephalopathy of prematurity, the white matter injury described is 
characterised by destructive lesions and hypomyelination rather than the 
more commonly encountered diffuse white matter abnormalities and the 
effects of neuroinflammation on grey matter development is less well studied. 
The timing, location and severity of insult are likely to be important in the 
pathogenesis of brain dysmaturation after preterm birth and sustained 
inflammation is a recognised feature of the neonatal immune response 
(Skogstrand et al. 2008; Dammann and Leviton 2014). Species differences in 
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the neurobiology of key brain maturation events can therefore make human 
comparisons to animal models difficult to interpret (Hodge et al. 2019; 
Gussenhoven et al. 2018).  
 
1.5.2 Primary human tissue 
Neuropathological studies have highlighted the role of microglial activation, 
oxidative stress and nitrosative injury in the pathogenesis of white matter 
disease and associated grey matter abnormalities including diffuse axonal 
injury and reduced cortical density (Haynes et al. 2008; Haynes et al. 2009; 
Haynes and van Leyen 2013; Andiman et al. 2010). However, post-mortem 
analysis provides only a single reading with little insight into the preceeding 
developmental trajectory. 
 
Dissociated cells or organotypic slice cultures using fetal tissues have 
advanced understanding of progenitor cell behaviour and cortical 
development (Subramanian et al. 2017; Mayer et al. 2019) but access to 
human fetal brain tissue is limited and cultures cannot be maintained long-
term, limiting opportunities for experimental manipulations.  
 
1.5.3 Modelling neurodevelopment using iPSCs 
The use of induced pluripotent stem cells (iPSCs) reprogrammed from 
human somatic cells offer the opportunity to study specific aspects of human 
neurodevelopment in vitro. 
 
Takahashi et al. first generated human induced pluripotent stem cells (iPSCs) 
through the viral transduction of adult human fibroblasts into a pluripotent 
state using four transcription factors: Oct3/4, Sox2, c-Myc and Klf4 
(Takahashi et al. 2007). iPSCs have the ability to self-renew indefinitely and 
form any cell type in the human body under the right conditions.  
 
iPSCs reprogrammed towards neuroectoderm can be differentiated into 
neural progenitor cells and then specific neuronal sub-types with the addition 
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of growth factors and mitogens in chemically defined medium. Protocols have 
been established for the efficient generation of a highly enriched population 
of mature post-mitotic glutamatergic excitatory neurons capable of 
spontaneous and induced depolarisation and the formation of functional 
synapses (Stein et al. 2014; Bilican et al. 2014; Livesey et al. 2016). This 
monolayer system can be used to study the impact of environmental 
exposures on key processes of human neural development in vitro using 
quantifiable measures of neuronal maturation and morphology.  
 
Human iPSC models have advanced understanding of the cellular and 
molecular mechanisms underlying neurodevelopmental disorders with 
specific gene mutations but have also been applied to the study of complex 
disorders which result from a combination of genetic susceptibility and 
environmental exposure such as schizophrenia and ASD (Ardhanareeswaran 
et al. 2017). iPSC models of ASD have identified dysregulation of genes 
involved in cell proliferation, neuronal differentiation and synaptogenesis 
suggesting a selective vulnerability in early cortical development (Mariani et 
al. 2015; Schafer et al. 2019). ASD is more prevalent in children who were 
born preterm and is also associated with neuroinflammation (Matta, Hill-
Yardin, and Crack 2019), suggesting that immune dysregulation may lead to 
a spectrum of neurodevelopmental disorders with common underlying 
neurobiology. 
 
iPSC-derived cortical neurons have a phenotype and transcriptomic profile 
resembling fetal brain development (Stein et al. 2014; Livesey et al. 2016), 
making this scalable system a promising tool for the study of preterm brain 








1.6 Aims and hypotheses  
Perinatal inflammation is associated with an increased risk of neonatal 
morbidity and a range of adverse neurodevelopmental outcomes. However, 
the immune mechanisms underlying these associations remain poorly 
understood. Studies investigating the association of specific inflammatory 
mediators with imaging features of brain injury have so far been limited to 
cranial ultrasound and conventional structural MRI and outcomes assessed 
beyond the neonatal period are subject to environmental confounders. This 
thesis aims to identify specific immune mediators associated with atypical 
brain development after preterm birth by addressing three main hypotheses: 
 
I. (a) The umbilical cord blood profile of preterm infants will be pro-
inflammatory when compared to term-born controls (b) Specific 
inflammation-associated proteins in umbilical cord blood will be 
predictive of histologic chorioamnionitis in preterm infants (c) The 
blood immune profile on postnatal day 5 will be altered in preterm 
infants who were exposed to histologic chorioamnionitis. 
 
II. Specific inflammation-associated proteins in postnatal blood taken 
on day 5 will be associated with white matter microstructure in 
preterm infants characterised by diffusion MRI metrics (PSMD and 
PSNDI) at term-equivalent age. 
 
III. Specific proteins associated with systemic inflammation after 
preterm birth will be associated with altered neuronal maturation 












2 Materials and methods 
2.1 Patient recruitment 
2.1.1 Participants 
Participants were recruited to the Theirworld Edinburgh Birth Cohort Study, a 
single-centre longitudinal study of preterm birth with detailed biosampling and 
brain imaging from birth to 5 years (Boardman et al. 2020).  
 
2.1.2 Ethics 
Ethical approval was obtained from the UK National Ethics Service (South 
East Scotland Research Ethics Committee 16/SS/0154) and parents 
provided written informed consent.  
 
2.1.3 Inclusion and exclusion criteria 
Infants were delivered at the Simpson Centre for Reproductive Health, Royal 
Infirmary of Edinburgh, UK between February 2017 and April 2019. Cases 
were infants delivered before 32 weeks of pregnancy based on first trimester 
ultrasound, while controls were healthy term-born infants delivered after 37 
weeks. Infants with major congenital anomaly or contra-indications to MRI 
were excluded. Term-born infants who required admission to the neonatal 
unit were also excluded. 
 
2.1.4 Recruitment 
I led study recruitment with assistance from Clinical Research Fellow, Dr. 
David Stoye, and Research midwife, Gillian Lamb. Potential participants were 
identified using electronic patient records at the Royal Infirmary of Edinburgh.  
Antenatal consent was obtained where possible to enable collection of cord 
blood and placenta at delivery. Postnatal consent was obtained for infants if 




Consent to the study was gained in two stages: (1) for perinatal and neonatal 
sampling including brain MRI, and (2) for assessments following MRI to the 
age of 5 years.  
To generate a control group representative of the general population with 
regard to mode of delivery and SIMD, term-born participants were recruited 
from a variety of sources including admissions for induction of labour, 
elective caesarean section lists and community outpatient clinics throughout 
NHS Lothian. 
During the study period, the parents of 339 term infants were approached 
and 85 (25%) were recruited. Of the 188 eligible preterm infants admitted to 
the neonatal unit, all were approached and 153 (81%) were recruited.  
 
2.2 Clinical data collection 
2.2.1 Data collection procedure 
Antenatal records were used to identify maternal age, parity, body mass 
index (BMI), maternal medical history, complications of pregnancy, mode of 
delivery, and exposure to antenatal steroids and magnesium sulphate. 
Neonatal electronic patient records were used to identify gestational age at 
delivery, sex, birthweight, bronchopulmonary dysplasia (BPD), early onset 
sepsis (EOS), late onset sepsis (LOS), meningitis, necrotising enterocolitis 
(NEC) and retinopathy of prematurity (ROP). 
 
2.2.2 Definitions 
Bronchopulmonary dysplasia (BPD) The need for supplemental oxygen or 
respiratory support at 36+0 weeks gestational age. 
Early-onset sepsis (EOS) Onset before 72 hours of life. Positive blood 
culture and/or antibiotic treatment for at least 5 days. 
Late-onset sepsis (LOS) Onset after 72 hours of life. Positive blood culture 
and/or antibiotic treatment for at least 5 days. 





Prolonged rupture of membranes (PROM) Rupture of membranes >24 
hours prior to delivery. 
Retinopathy of Prematurity (ROP) Requiring treatment with laser therapy 
or anti-VEGF. 
 
2.3 Dried blood spot collection 
2.3.1 Collection procedure 
Dried blood spot samples (DBSS) were taken from the umbilical cord 
following delivery for both preterm cases and term-born controls. For preterm 
infants, additional samples were collected on day 5 of life if a clinical sample 
was indicated. DBSS were obtained using a FTATM DMPK-A Card 
(WhatmanTM GE Healthcare).  
 
2.3.2 Processing and storage 
Bloodspot cards were dried at room temperature and then stored at -20° C 
until analysis at the Statens Serum Institut (Center for Neonatal Screening, 
Copenhagen, Denmark) which was performed by Dr. Nis Borbye-Lorenzen 
and Dr. Kristin Skogstrand.  
 
2.3.3 Immunoassay 
A customised multiple sandwich immunoassay based on flowmetric Meso-
Scale technology was used to measure blood spot levels of Interleukin(IL)-
1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-17, IL-18, Monocyte 
chemotactic protein-1 (MCP-1), Macrophage inflammatory protein-1a (MIP-
1a), Macrophage inflammatory protein-1b (MIP-1b), Tumor necrosis factor-a 
(TNF-a), Tumor necrosis factor-β (TNF-β), Brain-derived neurotropic factor 
(BDNF), Granulocyte-macrophage colony-stimulating factor (GM-CSF), 
Interferon-g (IFN-g ), C-reactive protein (CRP), matrix-metalloproteinase 9 
(MMP-9), Regulated upon activation, normal T cell expressed and secreted 





Two 3.2 mm disks from the DBSS were punched into each well of Nunc 96-
well polystyrene microwell plates (#277143, Thermo Fisher Scientific). 130 µl 
extraction buffer (PBS containing 1% BSA (Sigma Aldrich #A4503), 0.5% 
Tween-20 (#8.22184.0500, Merck Millipore), and complete protease inhibitor 
cocktail (#11836145001, Roche Diagnostics) was added to each well, and 
the samples were incubated for 1 hour at room temperature on a microwell 
shaker set at (900 rpm). The extracts were analyzed using U-plex plates 
(Meso-Scale Diagnostics (MSD), Maryland, US) coated with antibodies 
specific for IL-1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-12, IL-17, TNF-a, MIP-1b on 
one plate (#K15067 customized) and BDNF, GM-CSF, IL-10, IL-18, IFN-g, 
TNF-b, MCP-1, MIP-1a on another (#K151AC customized) (both MSD).  
 
Supplier’s instructions were followed, and extracts were analysed undiluted. 
A third multiplex analysis was developed in-house applying extracts diluted 
1:10 in diluent 7 (#R54BB, MSD) using antibodies specific for C3 (HYB030-
07 and HYB030-06, SSI Antibodies, Copenhagen, Denmark), C5a (10604-
MM04 and 10604-MM06, Sino Biological, Eschborn, Germany), C9 (R-plex 
kit #F21XZ, MSD), MMP-9 (BAF911 and MAB911), RANTES (MAB278 and 
AF278NA) and CRP (BAM17072 and MAB1701) (all R&D Systems, 
Minneapolis, US) for coating the U-plex plate and for detection, respectively. 
Coating antibodies (used at 1 µg/mL, except CRP used at 10 ng/mL) were 
biotinylated (using EZ-Link Sulfo-NHS-LC-Biotin #21327, Thermo Fisher 
Scientific) in-house (if not already biotinylated at purchase) and detection 
antibodies were SULFO-tagged (R91AO, MSD), both at a challenge ratio of 
20:1.  
 
The following calibrators were used: C3: #PSP-109 (Nordic Biosite, 
Copenhagen, DK), C5a: #10604-HNAE (Sino Biological), C9: #F21XZ (from 
R-plex kit, MSD), MMP-9: #911-MP, RANTES: #278-RN and CRP: #1707-
CR/CF (all from R&D Systems). Calibrators were diluted in diluent 7, 




diluted in diluent 3 (#R50AP, MSD). Controls were made in-house from part 
of the calibrator solution in one batch, aliquoted in portions for each plate and 
stored at -20°C until use. The samples were prepared on the plates as 
recommended from the manufacturer and were immediately read on the 
QuickPlex SQ 120 (MSD). Analyte concentrations were calculated from the 
calibrator curves on each plate using 4PL logistic regression using the MSD 
Workbench software.  
 
Intra-assay variations were calculated from 16 measurements of a pool of the 
same control sample on the same plate. Inter-assay variations were 
calculated from controls analysed in duplicate on each plate during the 
sample analysis, 4 plates in total. Limits of detection were calculated as 2.5 
standard deviations from duplicate measurements of the zero calibrator. The 
higher detection limit was defined as the highest calibrator concentration. 
Median intra-assay variation was 8.2% and median inter-assay variation was 
















BDNF  1.05 41000 2.71 3.84 
C3  13739 50000000 3.62 15.20 
C5a  544 16700000 5.60 19.10 
C9  8.38 3300000 5.60 12.80 
CRP 89.0 100000000 16.70 34.50 
GM-CSF 0.101 12500 4.19 7.86 
IFN-g  0.646 34875 3.24 6.29 
IL-1β 0.0260 4788 11.90 10.80 
IL-2 0.340 2688 11.30 14.70 
IL-4 0.00956 2700 16.10 16.80 
IL-5 0.125 5125 12.00 9.67 
IL-6 0.452 2650 11.10 20.9 
IL-8 0.0684 2575 10.9 15.0 
IL-10 0.0886 4625 4.13 5.56 
IL-12p70 0.157 9063 10.30 17.00 
IL-17 0.286 47375 13.50 11.40 
IL-18 0.199 50500 3.36 6.58 
MCP-1 1.28 7400 2.55 6.99 
MIP-1α 0.960 7500 2.71 6.32 
MIP-1β 1.73 2325 13.8 5.39 
MMP-9 24.1 5000000 6.29 25.10 
RANTES 37.9 1600000 10.10 29.00 
TNF-α 0.272 4538 11.80 4.48 
TNF-β 0.0250 5050 2.52 3.90 
 





2.4 Placental histopathology 
2.4.1 Collection and storage 
After delivery, placentae were formalin fixed and stored at 4°C. Distal and 
proximal sections of the umbilical cord, a roll of extraplacental membranes 
and four full thickness sections from each quadrant were collected.  
 
2.4.2 Placental reporting 
All sections were stained with H&E and reported by an experienced perinatal 
pathologist (Dr. Margaret Evans). Placental reaction patterns were reported 
according to the site of inflammation, using a structured system (Redline et 
al. 2003). Histologic chorioamnionitis was defined as the presence of an 
inflammatory response in the placental membranes of any grade or stage. 
Maternal and fetal inflammatory responses were defined as shown in Table 
2-2.  
 
Maternal inflammatory response 
(MIR) 




Necrotising chorioamnionitis  
Intervillositis  
 
Table 2-2. Definitions of maternal and fetal inflammatory responses. 
 
2.5 MRI data collection 
2.5.1 MRI procedure 
Structural and diffusion MRI brain scans were performed on a Siemens 
Magnetom Verio 3T scanner (Siemens Healthcare Gmbh, Erlangen, 
Germany) using a 16-channel matrix phase array head coil. Infants were 
scanned at term-equivalent age (37-44 weeks) in natural sleep with 




protection, flexible earplugs and neonatal earmuffs (MiniMuffs, Natus Medical 
Inc., CA) were used. I was responsible for the medical supervision of infants 
during scanning with assistance from research midwife, Gillian Lamb.  
 
2.5.2 Imaging acquisition protocol 
Infants were scanned to acquire: 3D T1-weighted (T1w) MPRAGE volume 
(TR= 1970 ms, TE= 4.69 ms, inversion time= 1100 ms, flip angle= 9° 
acquisition plane= sagittal, voxel size= 1 x 1 x 1 mm3, FOV= 160 mm, 
acquisition time= 3:09 min), axial T2-weighted BLADE (TR=4100 ms, TE= 
207 ms, voxel size= 0.7 x 0.7 x 3.0mm3, FOV= 220 mm, acquisition time= 
2:29 min), T2-weighted SPACE (TR=3200 ms, TE= 409 ms, acquisition 
plane= sagittal, voxel size 1 x 1 x 1 mm3, FOV= 128 mm, acquisition time= 
2:13 min), SWI (TR= 28 ms, TE= 20 ms, voxel size= 0.8 x 0.8 x 3.0 mm3, 
acquisition time= 2:23 min) and axial T2-weighted FLAIR BLADE (TR= 
10000, TE= 130, voxel size= 0.9 x 0.9 x 3.0 mm3, acquisition time= 3:22 
min). Diffusion MRI data were acquired in two parts with interspersed T2-
weighted (b=0 s/mm2) volumes: part 1 consisting of 8 b=0 s/mm2 and 64 
diffusion-weighted b=750 s/mm2, and part 2 consisting of 8 b=0 s/mm2, 3 
b=200 s/mm2, 6 b=500 s/mm2 and 64 b=2500 s/mm2 single-shot spin-echo 
echo planar imaging (EPI) volumes acquired with 2 mm isotropic voxels (TR= 
3500ms, TE= 78 ms, FOV= 256 mm, acquired matrix 128 x 128, acquisition 
time 4:29 + 5:01 min). 
 
2.5.3 Structural reporting 
Structural images were reported by a Paediatric Radiologist with experience 
in neonatal MRI (Dr. Alan J. Quigley) using an established system (Leuchter 
et al. 2014). Images with evidence of post-haemorrhagic ventricular 
dilatation, cystic periventricular leukomalacia or central nervous system 






Digital Imaging and Communication on Medicine (DICOM) image files for 
both structural and diffusion MRI were converted to Neuroimaging 
Informatics Technology Initiative (NIFTI) format. Diffusion MRI volumes were 
denoised using a Marchenko-Pastur-PCA based algorithm (Veraart et al. 
2016; Tournier et al. 2019). Eddy current, head movement and EPI geometric 
distortions were corrected using outlier replacement and slice-to-volume 
registration (Andersson and Sotiropoulos 2016; Andersson et al. 2016; 
Andersson et al. 2017; Jenkinson et al. 2012; Andersson, Skare, and 
Ashburner 2003) and bias field inhomogeneity correction was applied 
(Tustison et al. 2010).  
 
2.5.5 Peak width of skeletonised water diffusion parameters 
A multi-modality template was constructed using data from 50 term born 
infants with DTI-TK and all the subjects were aligned (Blesa et al. 2020; 
Zhang et al. 2006). The water diffusion tensor derived maps (MD, AD, RD 
and FA) of each subject were calculated after registration. The NODDI maps 
were calculated in the subject’s native space with the NODDI-Bingham model 
using cuDIMOT (Tariq et al. 2016; Hernandez-Fernandez et al. 2019) and 
then the intracellular volume fraction [NDI] was then propagated to the 
template space using the previously calculated transformations. The main FA 
skeleton template was created by thresholding at 0.15, and individual FA 
maps were projected onto this skeleton. Using this projection, the remaining 
water diffusivity and NODDI maps were also projected onto the white matter 
skeleton. A custom mask was created by editing the skeleton mask to 
remove CSF and grey matter contaminated areas, and by removing tracts 
passing through the cerebellum, the brainstem and subcortical grey matter 
areas using ITK-Snap (Yushkevich et al. 2006). The resulting skeletonized 
maps were then multiplied by the custom mask. Peak width skeletonised 
mean diffusivity (PSMD) and neurite density index (PSNDI) were calculated 
as the difference between the 95th and 5th percentiles on histogram analysis 




processing and generation of peak width skeletonised water diffusion 




Figure 2-1. Pipeline for the calculation of peak width skeletonised water diffusion 
parameters. 
Reproduced with permission (Blesa et al. 2020). 
 
2.6 Generation of iPSC-derived cortical neurons 
2.6.1 Maintenance of iPSCs 
All iPSCs were derived from human donor skin fibroblasts using an episomal 
non-integrating approach (Okita et al. 2011) under full ethical and IRB approval 
of the University of Edinburgh. The healthy control iPSC line used in this study 
has been previously described (Vasistha et al. 2019).  
iPSCs were maintained in 1:60 Matrigel (BD Biosciences) coated plastic 
dishes in E8 medium (Life Technologies) at 37°C in 5% CO2. Media was 
changed daily, and cells were passaged using a Dispase/Collagenase enzyme 
mix (1:1) once they reached 90% confluence.  
 
2.6.2 Generation of anterior NPCs 




using an established neural conversion protocol (Bilican et al. 2014; 
Chambers et al. 2009; Stacpoole et al. 2011). Dual SMAD inhibition (blocking 
two signalling pathways used by SMADs: bone morphogenic protein, BMP 
and transforming growth factor b, TGF-b) was used to differentiate iPSCs into 
neuroepithelial rosettes, which assume a default obligate anterior identity in 
chemically defined medium (CDM). Following 7 days in neuralisation 
medium, this was changed to base media (A-DMEM/F12, 1% P/S, 1% 
Glutamax, 1% N2), 0.4% B27, 2.5ng/mL FGF2. On day 18-22, neural 
rosettes were mechanically isolated, dissociated using Accutase (Sigma) and 
plated as a monolayer in plates coated with 1:100 Laminin and suspended in 
proliferation media (Base media, 0.1% B27, 10ng/mL FGF2). Media was 
changed every 48 hours and aNPCs were grown to 100% confluence.  
 
2.6.3 Differentiation of aNPCs into cortical neuronal cultures 
24-well plates with glass coverslips were prepared with a Poly-D-ornithine 
(Sigma) overnight incubation followed by 3 washes with cell culture grade 
water, 1-hour UV and then coated with 1:10 diluted Matrigel (BD 
Biosciences), 20 µg/ml Fibronectin (Sigma) and 10 µg/ml Laminin (Sigma). 
aNPCs were plated in default medium (A-DMEM/F12, 1% P/S, 0.5% 
Glutamax, 0.5% N2, 0.2% B27 and 2 µg/ml Heparin) at a density of 250,000 
per well and incubated at 37°C in 3% Oxygen. On day 7, default media was 
supplemented with 10 µM forskolin (Tocris) to encourage cell cycle exit. Cells 
were fed twice weekly throughout the protocol.  
 
2.6.4 GFP labelling of aNPCs 
aNPCs were transduced with lentivirus expressing GFP at a multiplicity of 
infection (MOI:1) which allowed sparse labelling before platedown. The 
generation of GFP lentivrus was performed by Dr. Pamela Brown 
(Biomolecular Core, University of Edinburgh Shared University Research 







Standard G banding chromosome analysis was performed in The Doctors Lab 
(TDL), London, UK, to confirm chromosome number and genetic abnormality 
throughout the course of this study. 
 
2.7 Immunohistochemistry 
2.7.1 Staining protocol 
All steps were performed at room temperature. Cells were fixed with 4% 
paraformaldehyde (PFA) for 15 minutes and then washed three times with 
PBS. Cells were permeabilised with 0.1% Triton X-100 and then blocked with 
6% goat serum for 30 minutes. Samples were then incubated with primary 
antibodies in 6% goat serum for 1 hour followed by Alexa Fluor-labelled 
secondary antibodies in 6% goat serum for 1 hour. Nuclei were counter-
stained with DAPI (Sigma) (5µg/ml). After final washes in PBS, coverslips 
were mounted on glass slides using FluorsaveTM reagent. 
 
The proportion of mitotic cells was studied by labelling with 10µM ethynyl 
deoxyuridine (EdU) for 24 hours. Media was replaced completely the 
following day and cells cultured for an additional 48 hours in the absence of 
EdU before fixation using 4% PFA. For detection, cells were permeabilised 
using 0.5% Triton X-100 and labelled using the EdU click-iT detection kit 
(Thermo-Fisher) according to manufacturer's instructions. Details of 







Isotype Manufacturer Concentration Secondary 
antibody 
OTX2 Goat R&D Systems 1:100 A11055 Donkey 
anti-goat 488 
PAX6 Rb BioLegend 1:100 A11008 Goat anti-
rabbit 488 
TBR2 Rb Abcam 1:100 A11008 Goat anti-
rabbit 488 
Nestin Mouse IgG1 Millipore 1:200 A21121 Goat anti-
mouse IgG1 488 
TUBB3 Mouse 
IgG2b 
Sigma  1:1000 A21242 Goat anti-
mouse IgG2b 647 
GFAP Rb Dako 1:1000 A21428 Goat anti-
rabbit 555  
 




Images were taken on a Zeiss Observer Z1 wide field microscope. Images 
were acquired with identical settings for parallel cultures. Regions of interest 
were identified by uniform nuclear staining and 3 regions were imaged per 
coverslip.  
 
Representative images were prepared with ImageJ (NIH). Images were then 
converted to TIFF format and analysed using Definiens Developer in 
collaboration with Dr. James Longden, to identify cell counts, EdU 







3 The inflammatory profile after preterm birth 
3.1 Introduction 
Histologic chorioamnionitis (HCA) is a leading cause of preterm birth 
(Romero et al. 2001; Goldenberg, Hauth, and Andrews 2000) and affects 40-
70% of very preterm infants (Dammann et al. 2004). Acute inflammation is 
characterised by the infiltration of neutrophils first into the choriodecidual 
junction and then into the fetal tissues. Histologically defined maternal 
inflammatory response (MIR) refers to infiltration of the fetal chorion and 
amnion (chorioamnionitis), whilst fetal inflammatory response (FIR) describes 
involvement of the blood vessels of the chorionic plate (vasculitis) or the 
umbilical cord (funisitis) (Cappelletti, Presicce, and Kallapur 2020). HCA is 
complicated by FIR in approximately 30% of very preterm infants with 
increasing risk associated with lower gestational age (Hecht et al. 2008; 
Mestan et al. 2009).  
 
HCA is associated with an increased risk of neonatal mortality and morbidity 
including lung disease, IVH, sepsis and necrotising enterocolitis (Bose et al. 
2011; Villamor-Martinez, Álvarez-Fuente, et al. 2019; Been et al. 2013; Hofer 
et al. 2013; Ozalkaya et al. 2016; Francis et al. 2019). HCA has also been 
implicated in the development of white matter injury, CP and 
neurodevelopmental impairment (Venkatesh et al. 2020; Shatrov et al. 2010; 
Leviton et al. 2010; Anblagan et al. 2016). When HCA involves both MIR and 
FIR, these risks appear to be increased further, suggesting that organ injury 
is mediated by a systemic fetal inflammatory response syndrome (FIRS). 
FIRS was initially defined as IL-6 >11ng/mL in umbilical cord blood (Gomez 
et al. 1998; Gotsch et al. 2007) but subsequent studies have shown an 
association between placental FIR and elevations in several circulating 
factors that reflect endothelial activation, leukocyte migration and the acute 
phase response (Hecht et al. 2011; Døllner et al. 2002; Mestan et al. 2009; 
Armstrong-Wells et al. 2015) leaving uncertainty about which immune 





Preterm infants have a distinct immune profile in umbilical cord blood when 
compared to term-born controls but this can be influenced by antenatal 
factors, environmental exposures and developmental regulation (Matoba et 
al. 2009). HCA has been associated with elevated cytokines (IL-1b, IL-6 and 
TNF-α), chemokines (IL-8, MCP-1, MIP-1β, RANTES), matrix 
metalloproteinases (MMP-1 and MMP-9) and CRP in umbilical cord blood 
(Hecht et al. 2011; Døllner et al. 2002; Mestan et al. 2009; Armstrong-Wells 
et al. 2015; Kacerovsky et al. 2013). Blood concentrations of inflammation-
related proteins are also more likely to remain elevated postnatally in preterm 
infants who were exposed to HCA (Leviton, Hecht, et al. 2011). If the period 
of immune dysregulation triggered by HCA is sustained, this suggests that 
mediators of the inflammatory response may provide a link between HCA 
and organ damage and that there may be a therapeutic window of 
opportunity for intervention following delivery. Given the delay before 
placental histopathology can be performed after birth, there remains an 
unmet need to identify a robust blood-based biomarker of FIRS to identify 
infants at highest risk of organ damage who may benefit from targeted anti-
inflammatory or immunomodulatory therapies. 
 
In this study, an immunoassay of 24 analytes customised to reflect the 
perinatal innate and adaptive immune response was used to analyse profiles 
from umbilical cord and postnatal blood with placental histopathology to test 
the hypotheses that (1) preterm birth is associated with a distinct pro-
inflammatory profile when compared to term-born controls, (2) specific 
inflammatory mediators in umbilical cord blood are associated with histologic 
chorioamnionitis and the fetal inflammatory response, and (3) exposure to 
histologic chorioamnionitis is associated with an altered immune profile on 






Participants were 192 infants, 133 preterm infants born £32+0 weeks’ 
gestation and 59 healthy term-born controls born >37+0 weeks, delivered at 
the Royal Infirmary of Edinburgh, UK and recruited to the Theirworld 
Edinburgh Birth Cohort Study. 
 
3.2.2 Dried blood spot collection 
Dried blood spot samples (DBSS) were taken from the umbilical cord 
following delivery for both preterm cases and term-born controls. For preterm 
infants, an additional sample was collected on day 5 of life. A customized 
multiple sandwich immunoassay based on meso-scale technology was used 
to measure blood spot levels of Interleukin(IL)1-b, IL-2, IL-4, IL-5, IL-6, IL-8, 
IL-10, IL-12p70, IL-17, IL-18, Monocyte chemotactic protein-1 (MCP-1), 
Macrophage inflammatory protein-1a (MIP-1a), Macrophage inflammatory 
protein-1b (MIP-1b), Tumor necrosis factor-a (TNF-a), Tumor necrosis 
factor-β (TNF-β), Brain-derived neurotropic factor (BDNF), Granulocyte-
macrophage colony-stimulating factor (GM-CSF), Interferon-g (IFN-g ), C-
reactive protein (CRP), matrix-metalloproteinase 9 (MMP-9), Regulated upon 
activation, normal T cell expressed and secreted (RANTES) and 
Complement components C3, C5a and C9.  
 
DBSS has been shown to be a robust method of handling samples for 
immunoassay analysis of inflammatory markers in whole blood with  
(Skogstrand et al. 2005). For a detailed description of the DBSS collection 
procedure, processing and analysis see Chapter 2, section 2.3. 
 
3.2.3 Placental histopathology 
Placental examination was performed by an experienced perinatal 




to the site of inflammation, using a structured system (Redline et al. 2003). 
Histologic chorioamnionitis (HCA) was defined as the presence of an 
inflammatory response in the placental membranes of any grade or stage. 
Maternal inflammatory response (MIR) was defined as the presence of 
chorionitis, chorioamnionitis or intervillositis. Fetal inflammatory response 
(FIR) was defined as the presence of vasculitis in the chorionic plate or 
funisitis involving any vessel of the umbilical cord. 
 
3.2.4 Statistical analysis 
Participant characteristics were compared using Student’s T test or Mann-
Whitney U to compare distributions, and Chi-square tests were used to 
compare proportions. Analytes with values less than the level of detection 
(<LOD) were assigned the lowest detectable level prior to statistical analysis, 
and analytes with concentrations <LOD in ≥75% of samples were excluded 
from subsequent statistical analysis.  
 
To investigate group differences in cord blood immune mediator profiles 
between preterm infants and term-born controls, the Mann-Whitney U was 
used with Bonferroni correction for multiple tests. A principal component 
analysis (PCA) was used to identify analytes contributing to variance in the 
cord blood profile and analytes that contributed to PCs with eigenvalues >1 
were then entered as independent variables in a logistic regression model to 
predict preterm or term category. Analytes contributing to variability within 
PCs predictive of gestational category were then investigated individually 
using Pearson correlation to identify developmentally regulated analytes 
most strongly correlated with gestational age.  
 
To investigate group differences in immune mediator profiles in preterm 
infants between those with and without exposure to HCA the Mann Whitney-
U was used with Bonferroni correction for multiple tests. Associations that 
remained significant after correction were analysed in logistic regression 




concentration was the independent variable, and GA at birth was entered as 
a covariate. The predictive power of those analytes that were associated with 
HCA after adjustment for GA at birth was determined using receiver operator 
characteristic (ROC) analysis. Exploratory analyses were performed to 
compare the immune mediator profiles in umbilical cord blood and postnatal 
day 5 blood for infants exposed to HCA with placental MIR+FIR- versus 
MIR+FIR+ using Mann Whitney U. Statistical analyses were performed using 
SPSS version 24.0 (IBM Corp., Armonk, NY), with the exception of PCA, 
which was performed using R version 3.6.1 (R Core Team, 2019). 
 
3.3 Results 
3.3.1 Participant demographics 
DBSS were obtained for 133 preterm infants and 59 term-born controls. 
Clinical characteristics are shown in Table 3-1.  
 
Not all participants had data collected at all timepoints so subsets were used 







 Preterm n= 133 Term n= 59 
Mean gestational age, weeks 
(SD) 
29+0 (2.24)  
range 23+2 to 32+0 
39+4 (1.04)  
range 37+3 to 42+0 
Birthweight, g (SD) 1223 (406) 
range 454-2110 
3549 (515)  
range 2556-4800 
Male sex, n (%) 76 (57) 30 (51) 
Delivery mode, n (%): 
   Vaginal 
   Emergency caesarean 








26 (44)  















 5  (8) 













Antenatal steroids, n (%) 127 (96)  
Magnesium sulphate, n (%) 122 (92)  
Prolonged ROM, n (%) 29 (22)  
Early onset sepsis  9/124 (7)  
Late onset sepsis 16/121 (13)  
Bronchopulmonary dysplasia 34/121 (26)  
Necrotising enterocolitis 
   Medical management 





Retinopathy of prematurity 8/118 (6)  
Deaths before discharge 10/133 (8)  
 
Table 3-1. Clinical characteristics of participants. 
 
 
3.3.2 Umbilical cord blood profile associated with prematurity  
DBSS were obtained from the umbilical cord of 55 preterm infants and 59 
term born controls. 10 analytes (GM-CSF, IFN-γ, IL-2, IL-4, IL-5, IL-10, IL-
12p70, IL-17, MIP-1α and TNF-β) were <LOD in ≥75% of samples and were 




significant group differences remained for 9 immune mediators (p<0.004). 




Table 3-2. Cord blood analytes. 
 
Pro-inflammatory proteins IL-6, MCP-1 and CRP were elevated in the cord 
blood of preterm infants whilst BDNF, C3, C9, IL-18, MMP-9 and RANTES 
were increased in term-born controls. 
 Preterm n=55 Term n=59  
Analyte 
(pg/ml) 
Median Q1,Q3 Median Q1,Q3 P value 
BDNF 22.27 
 
6.04, 36.90 62.33 43.18, 113.68 <0.001 





C5a 3694 2421, 11471 7136 4060, 9444 
 
0.028 
C9 1237 215, 6902 12629 3609, 43156 
 
<0.001 
CRP 100.88 89.00, 
12054.79 
89.00 89.00, 89.00 <0.001 
IL-1β 0.26 
 
0.26, 0.49 0.11 0.02, 0.34 0.009 
IL-6 0.45 
 
0.45, 6.00 0.45 0.45, 0.45 <0.001 
IL-8 12.05 
 
5.75, 81.08 8.29 4.89, 14.71 0.049 
IL-18 25.62 
 
10.35, 38.34 41.27 27.50, 54.78 <0.001 
MCP-1 109.09 
 
68.69, 210.75 48.12 38.54, 66.63 <0.001 
MIP-1β 12.01 
 
7.47, 18.82 9.72 6.88, 18.24 0.397 
MMP-9 14001 4486, 40077 155886 87195, 
358085 
<0.001 
RANTES 1460 703, 2754 3128 1817, 5295 
 
<0.001 
TNF-α 0.27 0.27, 0.37 0.27 
 





PCA showed that the first five principal components (eigenvalues>1) 
explained 76% of the variance in the cord blood profile (Table 3-3), with the 
majority of variance explained by the first two (25% and 20% respectively). 
Projection of individual inflammatory profiles onto the first two principal 
components is shown in Figure 3-1. 
 
 




1 3.56 25.43 25.43 
2 2.85 20.33 45.76 
3 1.88 13.44 59.20 
4 1.29 9.21 68.42 
5 1.10 7.84 76.25 
6 0.85 6.07 82.32 
7 0.58 4.13 86.45 
8 0.50 3.55 90.00 
9 0.46 3.32 93.31 
10 0.31 2.22 95.53 
11 0.20 1.45 96.98 
12 0.19 1.38 98.36 
13 0.18 1.31 99.67 
14 0.05 0.33 100.00 
 







Figure 3-1. Projection of individual cord blood inflammatory profiles 
onto the first two principal components, grouped by gestational age category. 
 
 
In a logistic regression model to predict preterm or term category, principal 
components 1, 2 and 5 were found to be predictive of gestational age with a 
classification accuracy of 86% (95% CI 0.78-0.92), p value= 1.242e-14. The 
contribution of individual components to the regression model are shown in 
Table 3-4 and the percentage contribution of each analyte to variability in the 
cord blood profile is shown in Figure 3-2. 
 
 B  SE B b p value 
PC1 2.8189 0.7863 5.3424 0.000337 
PC2 -2.6162 0.5467 -4.4331 1.71e-06 
PC3 -0.1343 0.2946 -0.1850 0.648519 
PC4 0.8840 0.5917 1.0084 0.135172 
PC5 -0.8628 0.3907 -0.9076 0.027207 
 
Table 3-4. Logistic regression for the prediction of gestational age 









Figure 3-2. The percentage contribution of each analyte to variability in the cord blood 
profile. 
 
Amongst immune mediators contributing to variability within the principal 
components most predictive of gestational category, correlation analysis 
showed that cord blood BDNF was the most highly correlated with 
gestational age at birth (r= 0.555, p= 1.5433e-10). Correlation coefficients for 






Analyte Correlation coefficient p value 
BDNF 0.555 1.5433e-10 
MMP-9 0.482 5.6601e-8 
RANTES 0.311 0.001 
C3 0.229 0.014 
MIP-1β -0.100 0.290 
IL-1β -0.105 0.266 
TNF-α 0.024 0.799 
 
Table 3-5. Correlation between individual analytes and gestational age. 
 
3.3.3 Umbilical cord blood mediators associated with histologic 
chorioamnionitis 
Of 55 infants with umbilical cord blood sampling and placental 
histopathology, 24 (44%) were exposed to HCA during fetal life. Infants with 
HCA exposure had lower GA at birth than infants without HCA: mean GA 
28+0 weeks versus 29+5 weeks (p= 0.002), and were more likely to have 
prolonged rupture of membranes (ROM) prior to delivery (p=0.007). There 
were no statistically significant group differences in birthweight, infant sex, 
delivery mode or exposures to antenatal corticosteroids or magnesium 
sulphate for fetal neuroprotection. Participant characteristics are shown in 
Table 3-6 and umbilical cord blood analyte concentrations are shown in 
Table 3-7.  
 
 No HCA n= 31 HCA n= 24 
Gestational age, weeks (SD) 29+5 (1.69)  28+0 (2.75) 
Birthweight, g (SD) 1236 (420) 1157 (476) 
Male sex, n (%) 21 (68) 12 (50) 
Delivery mode, n (%): 
   Vaginal 







Antenatal steroids, n (%) 31 (100) 23 (96) 
Magnesium sulphate, n (%) 29 (94) 23 (96) 
Prolonged ROM, n (%) 4 (13) 11 (46) 
 





Table 3-7. Umbilical cord blood analyte concentrations for infants exposed to HCA compared 
to those not exposed. 
 
Those exposed to HCA had higher cord blood levels of C5a, C9, CRP, IL-1b, 
IL-6, IL-8 and MCP-1 (p<0.003, Bonferroni corrected). Of these 7 analytes, 5 
were associated with HCA after adjustment for GA at birth in regression 
models: C5a, IL-1b, IL-6, IL-8 and MCP-1 (b between 0.88 and 28.78, p< 
0.05). IL-8 concentration was the best predictor of HCA with an area under 
 No HCA n=31 HCA n=24  
Analyte 
(pg/ml) 
Median Q1,Q3 Median Q1,Q3 p value 
BDNF 21.40 4.15, 30.85 29.33 
 
6.24, 48.22 0.072 







2780 1943, 4172 6202 3612, 16933 <0.001 
C9 
 
583 153, 1483 4857 1285, 38747 <0.001 
CRP 89.00 89.00,195.02 8829.84 89.00, 
100702.67 
0.001 
IL-1β 0.03 0.03, 0.03 0.49 
 
0.03, 0.93 <0.001 
IL-6 0.45 0.45, 0.45 5.20 
 
0.56, 23.18 <0.001 
IL-8 7.54 3.38, 12.06 106.70 
 
25.54, 496.42 <0.001 
IL-18 28.06 15.38, 47.92 14.49 
 
8.39, 35.76 0.06 
MCP-1 85.40 65.06, 117.17 206.84 
 
104.07, 364.51 <0.001 
MIP-1β 8.91 4.32, 16.84 16.13 
 
11.07, 29.87 0.04 
MMP-9 11681 
 
2139, 20169 16664 5242, 70314 0.127 
RANTES 
 
1311 618, 2754 1541 716, 3350 0.519 
TNF-α 0.27 0.27, 0.56 0.27 
 




the curve (AUC) of 0.917 (SE 0.039), 95% CI 0.841 – 0.993, p<0.001. Table 
3-8 shows the AUC for each analyte and Figure 3-3 shows the ROC analysis. 
 
Analyte (pg/mL) AUC (SE) 95% CI p value 
IL-8  0.917 (.039) 0.841- 0.993 1.434e-07 
IL-6  0.848 (.056) 0.739- 0.958 0.000011 
IL-1β  0.845 (.059) 0.729- 0.961 0.000013 
MCP-1  0.786 (.066) 0.657- 0.916 0.000301 
C5a  0.778 (.064) 0.651- 0.904 0.000457 
C9  0.776 (.066) 0.646- 0.905 0.001 
CRP  0.754 (.071) 0.614- 0.894 0.001 
 




Figure 3-3. ROC curve analysis of cord blood analytes for the prediction of HCA. 
 
 
In an exploratory analysis of the 24 infants with HCA, 13 (54%) had evidence 
of FIR (MIR+FIR+). Of the 14 analytes investigated, only concentrations of 
IL-1β, IL-6 and IL-8 in umbilical cord blood were associated with exposure to 






Figure 3-4. Boxplots of cord blood analytes associated with evidence of placental FIR. 
 
 
3.3.4 Histologic chorioamnionitis is associated with an altered immune 
profile on day 5 after preterm birth 
Of 98 preterm infants with day 5 DBSS, 31 (32%) were exposed to HCA 
during fetal life. Infants with HCA exposure had lower GA at birth than infants 
without HCA: mean GA 28+2 weeks versus 29+4 weeks (p=0.004). Infants 
exposed to HCA were more likely to have been delivered vaginally (p<0.001) 
and more likely to have prolonged ROM prior to delivery (p<0.001). There 
were no statistically significant group differences in birthweight, infant sex or 
exposures to antenatal corticosteroids or magnesium sulphate. Participant 
characteristics are shown in Table 3-9.  
 
 No HCA n= 67 HCA n= 31 
Gestational age, weeks (SD) 29+4 (1.84)  28+2 (2.63) 
Birthweight, g (SD) 1248 (368) 1187 (421) 
Male sex, n (%) 39 (58) 18 (58) 
Delivery mode, n (%): 
   Vaginal 







Antenatal steroids, n (%) 63 (94) 30 (97) 
Magnesium sulphate, n (%) 61 (91) 30 (97) 
Prolonged ROM, n (%) 8 (11) 14 (45) 
EOS, n (%) 4 (6) 4 (13) 
 
Table 3-9. Characteristics of infants with day 5 DBSS who were exposed to HCA compared 
to those not exposed. 
 
HCA classification






























5 immune proteins on day 5 of life had a median level in preterm infants 
exposed to HCA outside the IQR for preterm infants who were not exposed, 
highlighted in bold (Table 3-10). Day 5 concentrations of C3 and MMP-9 




Table 3-10. Day 5 blood analyte concentrations for infants exposed to HCA compared to 
those not exposed. 
Analytes with a median level in preterm infants exposed to HCA outside the IQR for preterm 
infants without HCA are highlighted in bold. 
 
 No HCA n=67 HCA n=31  
Analyte 
(pg/ml) 
Median Q1,Q3 Median Q1,Q3 p 
value 
BDNF 28.49 14.36, 42.11 42.28 
 
26.16, 100.09 0.008 







4236, 10086 9505 7337, 13451 0.002 
C9 7463 
 
2526, 20740 18110 4761, 55877 0.028 





IL-1β 0.03 0.03, 0.08 0.05 
 
0.03, 0.11 0.065 
IL-6 0.45 0.45, .045 0.45 
 
0.45, 0.45 0.641 
IL-8 11.44 7.56, 19.44 29.26 
 
12.55, 39.53 0.012 
IL-18 35.78 22.68, 53.77 34.35 
 
21.98, 47.92 0.501 
MCP-1 136.03 108.84, 
203.28 
106.97 90.22, 148.65 0.010 
MIP-1β 7.88 5.50, 11.12 12.04 
 
7.22, 16.22 0.011 
MMP-9 56654 28342, 98231 240084 64199, 460437 
 
<0.001 





TNF-α 0.27 0.27, 0.27 0.27 
 




In an exploratory analysis of the 31 infants with HCA, 18 (58%) had evidence 
of FIR (MIR+FIR+). Of the 14 analytes investigated, only C3 concentration in 
postnatal day 5 blood was found to be associated with exposure to FIR 
(p<0.004, Bonferroni corrected), Figure 3-5. 
 
Figure 3-5. Boxplot of day 5 C3 in infants with evidence of placental FIR. 
 
33 infants had blood obtained from the umbilical cord at delivery and on 
postnatal day 5. Of 14 (42%) with HCA, 8 (57%) had evidence of FIR 
(MIR+FIR+). Longitudinal analysis confirmed that IL-1β, IL-6 and IL-8 were 
elevated in the umbilical cord blood of infants with FIR but were less 
discriminatory by postnatal day 5, whilst C3 remained significantly altered. 
Line graphs demonstrating analyte trajectories from birth to postnatal day 5 
















Figure 3-6. Analyte trajectories from umbilical cord to postnatal day 5. 
 
3.4 Discussion 
By combining placental histopathology with a customised array of immune 
mediators in umbilical cord blood and postnatal blood from a large group of 
mother-infant dyads, this study characterises marked differences in the 
systemic immune profile of preterm infants compared with term controls, 
highlights specific mediators that are highly predictive of HCA, and 
demonstrates that in preterm infants the immune profile of those exposed to 
HCA remains altered on day 5 after birth. 
 
The umbilical cord blood immune profile was distinctly pro-inflammatory in 
preterm infants with significant elevations in 3 markers of the acute phase 
response: IL-6, MCP-1 and CRP. In contrast, 6 proteins were elevated in 
term-born controls, suggesting developmental regulation: BDNF C3, C9, IL-
18, MMP-9 and RANTES. BDNF was the analyte most highly correlated with 
gestational age. BDNF belongs to the family of neurotrophins: an important 
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and synaptic plasticity during development (Huang and Reichardt 2001). 
Prematurity, placental dysfunction and fetal growth restriction have all been 
associated with reduced levels of BDNF (Matoba et al. 2011; Leviton et al. 
2017; D'Angelo et al. 2020; Flöck et al. 2016) which may have important 
implications for long-term brain health. Reduced BDNF in the neonatal period 
has been associated with increased risk of developing ASD (Skogstrand et 
al. 2019) whilst elevated BDNF in the weeks after preterm birth is associated 
with better cognitive performance in childhood (Kuban et al. 2018). IL-18, 
MMP-9 and RANTES are known to be influenced by both gestational and 
postnatal age (Leviton, Fichorova, et al. 2011; Królak-Olejnik, Beck, and 
Olejnik 2006; Flöck et al. 2016) and the complement system is under-
developed in preterm infants (McGreal, Hearne, and Spiller 2012; Grumach 
et al. 2014). 
 
This study demonstrates a strong association between histologic markers of 
placental inflammation and a systemic inflammatory response in the 
newborn. Umbilical cord blood IL-8 concentration was found to be the best 
predictor of exposure to HCA and exploratory analyses suggest that this 
relationship is driven by placental FIR. Several studies have shown that IL-8 
synthesis is enhanced in neonates (Schultz et al. 2002; Strunk et al. 2004; 
Thornton, Cody, and Yost 2012) and predictive of inflammatory complications 
such as sepsis and necrotising enterocolitis (Leviton et al. 2012; Zhou et al. 
2015; Wong et al. 2008; Maheshwari et al. 2014; Benkoe et al. 2014; Satar et 
al. 2008), suggesting that IL-8 is a promising biomarker of the neonatal 
systemic inflammatory response. 
 
This study also suggests that the systemic inflammatory response to 
histologic chorioamnionitis is sustained beyond delivery in preterm infants. 
Previous studies have demonstrated that the neonatal inflammatory 
response can be dysregulated and prolonged in the weeks after preterm 
birth, particularly following funisitis, which may be due to the intensity of the 




even genetic risk (Skogstrand et al. 2008; Leviton, Hecht, et al. 2011; Liston, 
Carr, and Linterman 2016). In this study, C3 and MMP-9 were elevated on 
day 5 after preterm birth in infants exposed to HCA in utero. Exploratory 
analyses suggest that placental FIR results in an altered trajectory of C3 
expression but contribution of adverse postnatal events to the day 5 immune 
profile cannot be excluded.   
 
The complement cascade plays a key role in the innate immune response 
(Merle, Noe, et al. 2015) but is a potent inflammatory system which when 
dysregulated can cause significant tissue damage following injury. The 
complement cascade can be activated through several mechanisms but all 
component pathways converge at Complement protein C3 (Merle, Church, et 
al. 2015). C3 participates in multiple key processes affecting developing brain 
architecture, including tagging of synapses for pruning by microglia (Schafer 
et al. 2012; Gorelik et al. 2018). Regulators of complement are low in preterm 
infants (Grumach et al. 2014) and this may contribute to an uncontrolled 
complement response in the context of neuroinflammation (Fragopoulou et 
al. 2019) and brain injury secondary to hypoxia-ischaemia (Rocha-Ferreira 
and Hristova 2015). Numerous studies beyond the neonatal period have also 
implicated complement C3 dysregulation in CNS pathology including 
neurodevelopmental disorders (Magdalon et al. 2020), multiple sclerosis 
(Werneburg et al. 2020), traumatic brain injury (Alawieh et al. 2018) and 
neurodegeneration (Wu et al. 2019). 
 
MMP-9 is a member of the zinc-dependent endopeptidases that 
prototypically cleave extracellular matrix (ECM), cell adhesion molecules and 
cell surface receptors. Matrix-metalloproteinases also modulate the 
inflammatory response through the regulation of endothelial barrier function, 
cytokine activity and chemotactic gradient formation but the outcome of 
proteolysis is context specific (Fingleton 2017).  
The ECM is a key regulator of neural network development and plasticity 




a critical window of CNS vulnerability may therefore have long-term 
consequences on structural connectivity (Reinhard, Razak, and Ethell 2015). 
MMP-9 is higher in the CSF of preterm infants with post haemorrhagic 
ventricular dilatation (PHVD) when compared to those without brain injury 
(Okamoto et al. 2010) and elevated peripheral MMP-9 is associated hypoxia-
ischaemia in animal models, correlating with severity of injury in human 
infants born at term (Walsh et al. 2011; Bednarek et al. 2012; Savard et al. 
2015). 
 
Whilst this study analysed a large number of inflammation-associated 
proteins that are important in the innate and adaptive immune response in 
the newborn, a limitation is that the cytokine response is governed not only 
by environmental insults but also by genetic factors and maternal 
inflammatory status (Dammann and O'Shea 2008; Holst and Garnier 2008; 
Sheikh et al. 2016). Potential risks or resilience conferred by the genome or 
maternal immune influences were not able to be examined. Instead antenatal 
inflammation was characterised using placental histopathology, which is most 
closely associated with fetal inflammatory responses. 
 
Exploratory longitudinal analysis suggests that the systemic immune 
response to HCA is sustained but cross-sectional data analysis on day 5 may 
be confounded by neonatal complications such as invasive ventilation, sepsis 
and IVH.  
 
The rate of placental FIR was high in this study (54-58% of all HCA cases 
were MIR+FIR+) but sample size did not permit sub-group analysis based on 
gestational age. Given the developmental regulation of immune responses 
and the increased risk of FIR with lower gestational age, this would be 
interesting to consider in future work.  
 
Studies have shown that analytes measured from DBSS correlate with 




interchangeable (Massaro et al. 2019). In this study, no analyte 
concentrations were above the upper limit of detection but several 
participants had analyte values below the lower limits of detection. The 
majority of term-born controls had CRP and TNF-α concentrations <LOD 
whilst values for IL-4 and IL-10 were <LOD in all participants. Whilst these 
results may reflect the reduced incidence of systemic inflammation in healthy 
term infants and low circulating levels of anti-inflammatory proteins in all 
newborns, future studies are needed to explore the balance of damaging and 
protective factors. 
 
Whilst efforts were made to facilitate the recruitment of infants from a variety 
of sources, the demographics of families who were approached to participate 
but did not give consent were not able to be examined and so potential 
sampling bias could not be explored. However, participants were successfully 
recruited from all five SIMD quintiles and the proportion of infants delivered 
vaginally was similar in both groups.  
 
3.5 Conclusions 
By combining placental histopathology with a comprehensive assessment of 
immune mediators, this study shows that preterm infants have a distinct pro-
inflammatory profile in umbilical cord blood at birth and IL-8 concentration 
predicts exposure to HCA. The immune profile of infants exposed to HCA 
remains altered on day 5 after birth, suggesting that there may be a 
therapeutic window for targeted intervention using anti-inflammatory or 
immunomodulatory therapies to reduce the risk of complications associated 
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4.1 Introduction 
Preterm birth affects around 15 million births annually (Chawanpaiboon et al. 
2019), and is an important cause of CP, cognitive impairment, autism 
spectrum disorder and psychiatric disease later in life (Twilhaar et al. 2018). 
MRI studies reveal a cerebral phenotype of preterm birth that is associated 
with later function, and includes diffuse white matter disease, dysconnectivity 
of developing networks, and structural alterations in cortical and deep grey 
matter (Boardman et al. 2010; Kapellou et al. 2006; Ball et al. 2017; Galdi et 
al. 2020; Batalle et al. 2017). These image features are manifest by term-
equivalent age, which suggests that interventions to prevent injury and 
restore typical development may need to be applied during the perinatal 
period. 
 
Immune dysregulation at a critical point in neurodevelopment is strongly 
implicated in the pathogenesis of the encephalopathy of prematurity, which 
can be conceptualised as white matter injury and subsequent dysmaturation 
of diverse cellular processes resulting in atypical development of white and 
grey matter structures (Volpe 2019; Hagberg et al. 2015). Preterm infants 




levels of pro-inflammatory cytokines and lower levels of neuroprotective 
growth factors compared to infants born at term (Skogstrand et al. 2008; 
Boardman et al. 2018), and there is evidence that both systemic inflammation 
and neuroinflammation are associated with overt forms of preterm brain 
injury. For example, elevated IL-1b, IL-6, IL-8 and IL-10 in umbilical cord and 
early postnatal blood is associated with intraventricular hemorrhage and 
white matter lesions soon after birth (Yoon et al. 1996; Duggan et al. 2001; 
Ellison et al. 2005; Leviton et al. 2018), and persistently elevated pro-
inflammatory proteins during the first 2 weeks after preterm birth are 
associated with increased risk of cerebral palsy (Kuban et al. 2014; Carlo et 
al. 2011) and impaired neurocognitive development in infancy and childhood 
(O'Shea et al. 2012; O'Shea et al. 2013; Hansen-Pupp et al. 2008; Kuban et 
al. 2014; Leviton et al. 2016; Yanni et al. 2017; Kuban et al. 2017). 
Furthermore, specific co-morbidities of preterm birth characterised by 
systemic inflammation, including histologic chorioamnionitis and necrotising 
enterocolitis, are associated with abnormal white matter on MRI (Shah et al. 
2008; Ball et al. 2017; Anblagan et al. 2016; Barnett et al. 2018). However, 
previous study designs leave uncertainty about which immune mediators are 
associated with white matter dysmaturation. 
 
Diffusion tensor imaging (DTI) and neurite orientation and dispersion imaging 
(NODDI) support inference about the microstructural properties and 
geometrical organisation of developing white matter (Zhang, Schneider, et al. 
2012; Tariq et al. 2016; Pietsch et al. 2019). The integration of DTI scalars 
and NODDI metrics have recently been optimised for studying the neonatal 
brain and histogram analyses provide a single measure of generalised white 
matter microstructure. Peak width of skeletonised mean diffusivity (PSMD) 
and peak width of skeletonised neurite density index (PSNDI) are both 
altered in preterm infants at term-equivalent age when compared to term-
born controls, indicating that these are useful biomarkers of white matter 





Identification of immune mediators of generalised dysconnectivity during the 
perinatal period is important for elucidating new targets for neuroprotection 
therapies. In this study, an immunoassay of 24 analytes customised to reflect 
perinatal innate and adaptive immune responses, was used to analyse 
postnatal day 5 blood samples with brain MRI to test the hypothesis that 
specific immune mediators link systemic inflammation with atypical white 
matter development in preterm infants.  
 
4.2 Materials and methods 
4.2.1 Participants 
Participants were 71 preterm infants born before £ 32+0 weeks’ gestation, 
delivered at the Royal Infirmary of Edinburgh, UK and recruited to the 
Theirworld Edinburgh Birth Cohort Study. Exclusion criteria included infants 
with major congenital abnormality, post-haemorrhagic ventricular dilatation 
defined as ventricular indices >97th centile +4mm, cystic periventricular 
leukomalacia, or contra-indications to 3T MRI.  
 
4.2.2 Blood sample collection 
Dried blood spot samples (DBSS) were taken from the umbilical cord 
following delivery and from blood drawn on day 5 of life using a FTATM 
DMPK-A Card (WhatmanTM GE Healthcare). Bloodspot cards were dried at 
room temperature and then stored at -20°C until analysis at the Statens 
Serum Institut (Center for Neonatal Screening, Copenhagen, Denmark). A 
customised multiple sandwich immunoassay based on meso-scale 
technology was used to measure blood spot levels of Interleukin(IL)-1b, IL-2, 
IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-17, IL-18, Monocyte chemotactic 
protein-1 (MCP-1), Macrophage inflammatory protein-1a (MIP-1a), 
Macrophage inflammatory protein-1b (MIP-1b), Tumor necrosis factor-a 
(TNF-a), Tumor necrosis factor-β (TNF-β), Brain-derived neurotropic factor 




Interferon-g (IFN-g ), C-reactive protein (CRP), matrix-metalloproteinase 9 
(MMP-9), Regulated upon activation, normal T cell expressed and secreted 
(RANTES) and Complement components C3, C5a and C9. A detailed 
description of the DBSS collection procedure, processing and analysis are 
provided in Chapter 2, section 2.3. 
 
4.2.3 MRI analysis 
Figure 4-1 summarises the pipeline for calculation of histogram-based 
metrics. A detailed description of MRI procedure, sequence acquisition and 
image processing are provided in Chapter 2, section 2.5. 
 
 
Figure 4-1. Imaging pipeline for the construction of PSNDI. 
(A) shows the custom white matter skeleton, (B) shows the calculation of PSNDI from a 
histogram analysis of neurite density index, and (C) shows a scatterplot of PSNDI versus 
gestational age at MRI scan. 
 
4.2.4 Statistical analysis 
Participant characteristics were compared using Student’s t-test or Mann-
Whitney U to compare distributions, and Chi-square tests were used to 











detection (<LOD) were assigned the lowest detectable level prior to statistical 
analysis, and analytes with concentrations <LOD in ≥75% of participants 
were excluded.  
To investigate relationships between systemic inflammation and white matter 
microstructure, principal component analysis was used to identify blood 
analytes contributing to variance in the postnatal day 5 inflammatory profile. 
Analytes that contributed to principal components with eigenvalues >1 were 
entered as independent variables in multivariable linear regression models 
with PSMD and PSNDI as dependent variables, and GA at birth and scan as 
covariates.  
Statistical analyses were performed using SPSS version 24.0 (IBM Corp., 
Armonk, NY), with the exception of PCA, which was performed using R 




71 preterm infants (delivered £ 32+0 weeks of gestation) had blood taken on 
postnatal day 5 and MRI performed at term-equivalent age (Figure 4-2). 
Clinical characteristics of participants are shown in Table 4-1. 
 
 
Figure 4-2. Recruitment flowchart. 
 
Eligible preterm <32w 
admitted to neonatal 
unit = 188
Included in study = 71
Declined to participate = 35
Consented = 153
Neonatal death = 6
VP shunt = 1
Unable to have MRI (on respiratory 
support/too unwell/in another hospital = 8
Did not attend MRI = 4
Withdrew from study before MRI = 2  
Day 5 DBSS + MRI = 77 
Day 5 DBSS = 98
Data incomplete = 5





Mean GA at birth, weeks (range) 29+4 (23+6 - 32+0) 
Mean birthweight, g (range) 1284 (600-2060) 
Proportion of male infants (%) 58 
Antenatal steroids, any (%) 96 
Antenatal magnesium sulphate, any (%) 93 
Histologic chorioamnionitis, HCA (%) 30 
Sepsis (%) 18 
Necrotising enterocolitis, NEC (%) 6 
Bronchopulmonary dysplasia, BPD (%) 25 
Retinopathy of prematurity, ROP (%) 6 
Mean GA at scan, weeks (range) 41+0 (38+0-44+4) 
 
Table 4-1. Clinical characteristics of participants. 
 
 
4.3.2 Postnatal inflammation and white matter microstructure 
The mean PSNDI for the group was 0.238 mm2sec-1 x10-3 (SD 0.016), and 
mean PSMD was 0.601 mm2sec-1 x10-3 (SD 0.062). 
Using PCA, we found that five principal components (eigenvalues >1) 
explained 66% of the variance in the postnatal inflammatory profile, with most 
variance explained by the first two (23% and 15% respectively). Cumulative 










1 3.17 22.62 22.62 
2 2.14 15.28 37.89 
3 1.69 12.08 49.97 
4 1.27 9.06 59.02 
5 1.03 7.38 66.40 
6 0.97 6.94 73.35 
7 0.83 5.91 79.26 
8 0.66 4.69 83.94 
9 0.57 4.10 88.05 
10 0.54 3.82 91.87 
11 0.39 2.77 94.64 
12 0.38 2.71 97.35 
13 0.24 1.69 99.04 
14 0.13 0.96 100.00 
 
Table 4-2. Variance in the postnatal day 5 inflammatory profile. 
 
 
Fourteen analytes contributed to the first 5 principal components: BDNF, C3, 
C5a, C9, CRP, IL-1β, IL-6, IL-8, IL-18, MCP-1, MIP-1β, MMP-9, RANTES 










Of these 14 analytes, IL-8 was the only one to be associated with PSNDI at 
term equivalent age (b=0.221, p=0.037), in a multivariable model that 
explained 48% of the variance in PSNDI at term-equivalent age (F (16,54)= 
5.09, R2 adjusted=0.48, p<0.001), Table 4-3. Partial regression of day 5 IL-8 






 B SE B b 
Constant -1.574e-01   5.168e-02    
IL-8 1.258e-04   5.874e-05    .221  
GA 3.066e-03   9.007e-04    .369  
PMA at scan 7.370e-03   1.084e-03    .706  
 
Table 4-3. Multivariable regression for the prediction of PSNDI using day 5 analytes. 
 
 
Figure 4-4. Partial regression plot of day 5 IL-8 and PSNDI. 
 
None of the remaining 13 analytes were associated with PSNDI and there 
were no significant associations between any analyte and PSMD.  
 
4.4 Discussion 
By combining data from the postnatal immune profile with brain diffusion 
MRI, this study shows that elevated IL-8 in the first week of life is associated 
with white matter dysmaturation at term-equivalent age. 
 
IL-8 is a member of the CXC chemokine family and a mediator of the 




IL-8 can be secreted by innate and adaptive immune cells and a variety of 
CNS cells including astrocytes and microglia (Choi et al. 2014; Rustenhoven 
et al. 2016). IL-8 binds to target cells via the G-protein coupled receptors 
CXCR1 and CXCR2. These receptors are expressed throughout the CNS 
and are associated with key neurodevelopmental processes including cell 
migration, proliferation and differentiation, oligodendrocyte maturation, axonal 
growth and synaptic plasticity (Ubogu, Cossoy, and Ransohoff 2006; Semple, 
Kossmann, and Morganti-Kossmann 2010; Watson et al. 2020; Deverman 
and Patterson 2009). This suggests multiple potential mechanisms through 
which IL-8 dysregulation during a critical window of neurodevelopment may 
disrupt healthy CNS development.  
 
IL-8 dysregulation has been implicated in the pathology of several types of 
human brain injury across the life course. It is associated with blood brain 
barrier dysfunction in adult traumatic brain injury (Kossmann et al. 1997; 
Obermeier, Daneman, and Ransohoff 2013), with altered cerebral 
metabolism and poor neurodevelopmental outcome following neonatal 
hypoxic ischaemic injury (Bartha et al. 2004; Foster-Barber, Dickens, and 
Ferriero 2001) and with increased mortality in children following traumatic 
brain injury (Woodcock and Morganti-Kossmann 2013). Studies focused on 
the perinatal period report that elevated IL-8 in blood sampled from the 
umbilical cord or soon after birth is associated with overt white matter injury 
and cerebral palsy, neurodevelopmental impairment, and cognitive 
impairment in children born preterm, and it is one of the neonatal cytokines 
that is most strongly associated with subsequent diagnosis of autism among 
children born at term (Kuban et al. 2017; Leviton et al. 2019; Carlo et al. 
2011; Kuban et al. 2014; Silveira and Procianoy 2011; Heuer et al. 2019; 
Kinjo et al. 2011; Hansen-Pupp et al. 2008). Furthermore, studies 
investigating the maternal immune activation hypothesis and offspring mental 
health report that elevated maternal IL-8 during pregnancy is associated with 
alterations in brain structure and an increased risk of schizophrenia in 




suggests that inflammation associated with elevated IL-8 has a significant 
adverse impact on the developing brain with pervasive effects on both 
structure and function.  
 
To the author’s knowledge, this is the first study to integrate mediators of 
systemic inflammation with biomarkers of white matter microstructure in a 
representative group of preterm infants without major parenchymal brain 
injury. Strengths of the study include the selection of a large number of 
inflammation-associated proteins that are important in the innate and 
adaptive immune response in the newborn, and use of a data driven 
approach based on PCA to characterise the inflammatory profile associated 
with white matter microstructure. The choice of image features was 
principled, based on established characterisations of white matter 
dysmaturation in preterm infants, including water content and 
dendritic/axonal complexity within the white matter skeleton (Blesa et al. 
2020; Kunz et al. 2014b; Lynch et al. 2020).  
 
A limitation of the study is that potential risks or resilience conferred by the 
genome could not be explored and the sample size was not sufficient to 
perform sub-group analyses based on gestational age. 
Global measures of white matter microstructure were selected as 
microstructural properties have been shown to be substantially shared across 
the major white matter tracts of the newborn brain (Telford et al. 2017), and it 
was hypothesised that systemic inflammation exerts a global effect; different 
methods, such as those based on quantitative tractography, would be 
required to investigate hypotheses about tract specific or regional 
susceptibilities to immune dysregulation. 
 
4.5 Conclusions 
This study provides further support for a substantial role of generalised 




dysregulation may provide a link between systemic inflammation and brain 
dysmaturation. Given the potential role of immunomodulatory therapies for 
treating diseases of the central nervous system (Çakici et al. 2019; 
Wittenberg et al. 2019), and the availability of anti-IL-8 monoclonal antibody 
therapies, this finding has implications for the development of perinatal 












5 The effect of inflammation on the development of 
iPSC-derived cortical neurons 
 
5.1 Introduction 
Preterm birth is associated with an increased risk of neurocognitive problems 
involving executive function, attention, language processing, working memory 
and emotional regulation. Grey matter injury is a feature of the 
encephalopathy of prematurity and cortical dysmaturation may contribute to 
the cognitive and behavioural disturbances observed in preterm infants 
(Fleiss, Gressens, and Stolp 2020; Volpe 2019).  
 
MRI studies have shown that preterm infants have reduced volume of the 
cerebral cortex (Inder et al. 2005; Makropoulos et al. 2016), altered cortical 
microstructural organisation (Ball, Srinivasan, et al. 2013; Bouyssi-Kobar et 
al. 2018) and dysconnectivity of developing neural networks (Ball, Boardman, 
et al. 2013) when compared to term-born controls at term-equivalent age. 
These cortical alterations persist into childhood (Zhang et al. 2015; Peterson 
et al. 2000) and adolescence (Nosarti et al. 2008) and are associated with 
neurocognitive outcomes (Kapellou et al. 2006; Keunen et al. 2016; Bora et 
al. 2014; Rathbone et al. 2011; Gui et al. 2019; Ball et al. 2015; Kline et al. 
2019). 
However, the neurobiology of these imaging signatures remains unknown. 
The cerebral cortex is a complex and highly organised 6-layered structure 
composed predominantly of projection neurons which are glutamatergic and 
extend long range axons to other cortical regions and subcortical structures, 
and inhibitory gamma-aminobutyric acid (GABA)-expressing interneurons 
which usually project shorter axons within the same cortical region (Franco 
and Müller 2013). Both glutamatergic neurons and interneurons are affected 
by preterm birth (Malik et al. 2013; Stolp et al. 2019). Understanding the 




development is a crucial next step towards the development of 
neuroprotective strategies for preterm infants.  
 
All neurons and glia of the CNS are derived from neuroepithelial cells of the 
developing brain (Stiles and Jernigan 2010). Neural progenitor cells in the 
proliferative ventricular zone (VZ) are mitotic and initially undergo 
symmetrical divisions to increase the precursor pool whilst the neural plate is 
forming. Following closure of the neural tube on gestational week (GW) 4, 
neural progenitors transition into radial glia (RG) cells with potential to 
generate both neurons and glia. RG express PAX-6 and divide 
asymmetrically to create a proliferating RG and an immature neuron or a RG 
and an intermediate progenitor cell (IPC) (Taverna, Gotz, and Huttner 2014). 
IPCs can divide symmetrically to amplify the precursor pool further or 
undergo terminal division to create post-mitotic excitatory glutamatergic 
neurons. Once formed, neurons migrate radially from the proliferative regions 
of the VZ in an organised way to form the developing six layered neocortex 




Figure 5-1. Schematic illustration of mammalian neurogenesis. 
Reproduced with permission from (Molnár 2019), Copyright John Wiley & Sons, Inc. 
 
By PCW 24, the cerebral cortex has been populated by the full complement 




from the dorsal and ventral telencephalon occurs later, reaching peak density 
at term (Xu et al. 2011; Arshad et al. 2016). During migration, immature 
neurons extend and retract neurites which later become axons and dendrites 
once polarisation is determined.  
Cortical development during the third trimester of pregnancy represents a 
period of rapid brain growth with many complex dynamic cellular processes 
vulnerable to injury (Andescavage et al. 2017; Makropoulos et al. 2016). 
Highly regulated spatiotemporal gene expression is crucial for the cellular 
composition and cytoarchitecture of the developing neocortex (Kang et al. 
2011; Nowakowski et al. 2017) and the timing of progenitor cell expansion is 
a key determinant of cortical size (Picco et al. 2018). Single cell RNA 
sequencing of the human prefrontal cortex showed that RG in PCW 9 to 16 
were actively proliferating with a switch to neuronal differentiation in PCW 16 
to 26. This is accompanied by neural network formation, with genes related 
to axonal generation expressed in PCW 19 to 26 and synaptogenesis from 
PCW 23 (Zhong et al. 2018). 
 
Cytokines and chemokines are implicated in several key pathways for 
healthy cortical development, including neural progenitor cell proliferation, 
migration and fate determination (Deverman and Patterson 2009; Guidolin, 
Fede, and Tortorella 2019; Mousa and Bakhiet 2013). Perturbation of these 
processes due to inflammatory exposures in utero may contribute to the 
alterations in neural circuitry observed in association with preterm birth. For 
example, maternal immune activation has been associated with reduced 
NPC proliferation and premature cell cycle exit with resulting alterations in 
neuronal subtypes in the fetal cortex of offspring (Carpentier et al. 2013; 
Stolp et al. 2011; Stojanovska et al. 2018; Hester et al. 2018; Bilbo et al. 
2018). Whilst mechanistic links remain speculative, evidence from animal 
models suggests that dysregulation of cytokine networks can lead to 
significant alterations in fetal brain development (Gregg and Weiss 2005; Ma 
et al. 2014; Bernardino et al. 2008; Ahn, Lee, and Kim 2015; Neumann et al. 




regulation of progenitor cell pluripotency (Jiang et al. 2017; Jung et al. 2015; 
Krtolica et al. 2011). 
 
Whilst animal models offer insights into the impact of inflammation on brain 
structure and function, species differences in the timing of key brain 
maturation events can make comparisons of cellular, temporal and spatial 
vulnerability difficult to interpret (Semple et al. 2013; Workman et al. 2013).  
The developing human brain has an enhanced proliferative capacity and 
diverse subtypes of neural stem cells and intermediate progenitors to 
facilitate brain expansion, especially of the cortex (Silbereis et al. 2016). 
Induced pluripotent stem cells (iPSCs) reprogrammed from human somatic 
cells offer the opportunity to study cortical development in vitro. Functional 
and transcriptomic studies have shown that iPSC-derived cortical neurons 
have a phenotype and expression profile resembling fetal and early postnatal 
neurons (Stein et al. 2014; Livesey et al. 2016), making this system a 
promising tool to study the impact of inflammation on cortical development. 
Here we model the effect of immune mediators characteristic of the neonatal 
systemic inflammatory response (C5a, IL-6, IL-8, and TNF-a) on cortical 




5.2.1 Generation of iPSC-derived cortical neurons 
All iPSCs were derived from human donor skin fibroblasts using an episomal 
non-integrating approach (Okita et al. 2011) under full ethical and IRB approval 
of the University of Edinburgh. iPSCs were converted to anterior NPCs and 
then excitatory glutamatergic cortical neurons using an established protocol 






5.2.2 Model characterisation 
Anterior forebrain identity of NPCs was confirmed by the presence of 
Orthodenticle homeobox2 (OTX2). Radial glia (RG) cells were identified by 
the presence of Paired box 6 (PAX6), and intermediate progenitor (IP) cells 
by the presence of T-box protein 2 (TBR2) (Götz, Stoykova, and Gruss 1998; 
Englund et al. 2005).  
To observe the transitional morphology of NPCs developing into cortical 
neurons, a time course experiment was performed from day 0 to day 14. 
During the experimental window from day 14 to 21, cell populations were 
studied to identify the representative proportion of NPCs (Nestin +), cortical 
neurons (ß-III tubulin +) and glial progenitors (GFAP +). 
5.2.3 Experimental design 
The protocol for iPSC- derived cortical neuron generation was adapted to 
study the effect of complement and cytokine exposure on a mixed culture of 
NPCs and developing cortical neurons. NPCs were plated down on day 0. 
On day 14, C5a, IL-6, IL-8 or TNF-a (Peprotech) was added to the media. 
Previous studies have shown that preterm infants may be exposed to plasma 
interleukin concentrations of up to 4000 pg/mL and TNF-a of 534 pg/mL 
(Mestan et al. 2009; Leviton, Fichorova, et al. 2011; Nielsen et al. 2015; 
Sullivan et al. 2020). CSF expression of C5a ranges from 420 to 5240 pg/ml 
and CSF IL-8 concentrations may be 10-fold higher than in plasma (Ellison 
2005, Pataky 2015). Therefore, doses representative of the human 
inflammatory response were selected: 0.1ng/mL, 1ng/mL and 10ng/mL with 
an additional dose of 100ng/ml for experiments with IL-8. Cells were 
maintained in continuous culture with media changes every 48 hours until 
they were fixed for immunohistochemistry on day 21.  
 
Figure 5-2. Experimental design. 
+ inflammatory protein
Day 0 Day 21Day 7 Day 14




Primary outcome measures were: (1) Proportion of Nestin+ NPCs, (2) 
Proportion of βIII tubulin+ neurons, (3) Proportion of GFAP+ astrocytes and 
(4) Neurite length. For experiments to measure neurite length, aNPCs were 
transduced with lentivirus expressing GFP at a multiplicity of infection 
(MOI:1) which allowed labelling before platedown. Neurite length was then 




Cells were fixed for immunohistochemistry on day 21. Full details of the 
staining protocol and antibodies used are described in Chapter 2, section 2.7. 
Images were taken on a Zeiss Observer Z1 wide field microscope and 
representative images were prepared with ImageJ (NIH). Images were then 
converted to TIFF format and analysed using Definiens Developer to identify 
cell counts, EdU quantification and neurite length. 
 
5.2.5 Statistical analysis 
Statistical analysis was performed with GraphPad Prism 8.0 (GraphPad 
software San Diego, CA, USA). Each derivation of cortical neurons from 
NPCs was considered as n=1 and data was collected from a minimum of 3 
derivations for each experiment (range= 3-7). Data are presented as mean 
+/- s.e.m. with fold change in experimental conditions compared to control. 
Statistical analysis was performed using one-way analysis of variance 
(ANOVA) with post hoc Dunnett’s test for multiple comparisons. 
 
5.3 Results 
5.3.1 In vitro human stem cell model to study cortical neuron 
development 
Anterior forebrain NPCs were generated and maintained according to an 
established protocol (Bilican et al. 2014). Anterior forebrain identity was 
confirmed by the presence of Orthodenticle homeobox2 (OTX2) in cultures 




cells were identified by the presence of PAX6, and IP cells by the presence 
of TBR2 (Götz, Stoykova, and Gruss 1998; Englund et al. 2005). Images of 





Figure 5-3. Immunostaining of model characterisation. 
Representative images showing OTX2, PAX6 and TBR2 (scale bar: 50µm). 
 
By day 14, cultures included both NPCs and developing cortical neurons. 
Figure 5-4 shows the transitional morphology of NPCs into neurons shown 









Figure 5-4. Transitional morphology of NPCs  
developing into cortical neurons (scale bar: 50µm). 
 
 
During the experimental window from day 14 to 21, the culture contained a 
mixture of NPCs (Nestin+) and cortical neurons (ß-III tubulin+) with minimal 


























Figure 5-5. Representative images of cortical neuron cultures 
on (A) day 14 and (B) day 21 (scale bar: 50µm). 
 
Quantitative immunohistochemistry performed on day 21 (n=5) confirmed a 
mixed population of NPCs (Nestin+ 51.28 +/- 5.16) and neurons (TUBB3+ 




























Figure 5-6. Quantification of cell culture population from immunohistochemistry on day 21 
showing proportion of NPCs (Nestin+), cortical neurons (TUBB3+) and astrocytes (GFAP+). 
Data are represented as mean +/- s.e.m. 
 
 
5.3.2 The effect of inflammation on cortical neurogenesis 
To study cortical maturation in the context of inflammation, developing 
human iPSC-derived cortical neurons were exposed to cytokines associated 
with the neonatal systemic inflammatory response: C5a, IL-6, IL-8, TNF-a. 
Cultures were exposed for 7 days before immunostaining for markers of 
nuclear DNA (DAPI+), NPCs (Nestin+), cortical neurons (TUBB3+) and 
astrocytes (GFAP+). 
 
5.3.2.1 Effect of cytokines on nuclei number 
There were no significant differences in the mean nuclei number following 




Figure 5-7. Quantification of mean nuclei number following exposure to C5a, IL-6, IL-8 and 
TNF-a.  













































































































































































5.3.2.2 Effect of C5a on cortical neuron differentiation  
C5a was associated with an increase in the proportion of TUBB3+ neurons 
following a 7-day exposure at a dose of 10ng/ml. Mean difference was -0.491 
(95% CI -0.977 to -0.005), p=0.0470 (Figure 5-8). There were no significant 
differences in the population of Nestin+ NPCs or GFAP+ astrocytes. There 
was a trend towards a reduction in the proportion of mitotic cells using EdU 
labelling but this was not statistically significant (Figure 5-9). This suggests 
that the resulting increase in the proportion of post-mitotic neurons observed 
with exposure to C5a may be secondary to terminal differentiation rather than 





Figure 5-8. Quantification of cell population following exposure to C5a 
(A) Proportion of TUBB3+ neurons, (B) Proportion of Nestin+ NPCs and (C) Proportion of 


























































































































Figure 5-9. Quantification of mitotic cells using EdU labelling 
(A) Representative images for 10ng/ml C5a vs control (scale bar: 50µm), (B) EdU 
quantification demonstrating fold change compared to control. 
 
 
5.3.2.3 Effect of IL-8 on cortical neuron differentiation 
IL-8 was associated with an increased proportion of Nestin+ NPCs following 
a 7-day exposure at a dose of 100ng/ml. Mean difference was -0.3259 (95% 
CI -0.561 to -0.091), p= 0.0032 (Figure 5-10). There was a trend towards an 




Figure 5-10. Quantification of cell population following exposure to IL-8 
(A) Proportion of TUBB3+ neurons, (B) Proportion of Nestin+ NPCs and (C) Proportion of 






























































































































































5.3.2.4 Effect of IL-6 on cortical neuron differentiation 
IL-6 also appeared to influence the proportion of GFAP+ astrocytes in culture 
but results were not statistically significant (Figure 5-11). 
 
 
Figure 5-11. Quantification of cell population following exposure to IL-6 
 (A) Proportion of TUBB3+ neurons, (B) Proportion of Nestin+ NPCs and (C) Proportion of 
GFAP+ astrocytes. Data are presented as fold change compared to control. 
 
 
5.3.2.5 Effect of TNF-a  on cortical neuron differentiation 
There were no significant differences in cell populations following exposure to 





Figure 5-12. Quantification of cell population following exposure to TNF-a 
 (A) Proportion of TUBB3+ neurons, (B) Proportion of Nestin+ NPCs and (C) Proportion of 




















































































































































































































































































































































































































5.3.3 The effect of inflammation on neurite outgrowth 
Due to cell density, the incorporation of GFP prior to platedown of NPCs 
enabled sparse labelling to facilitate quantification of neurite length. Figure 5-
13 shows a representative image on day 21 of culture. 
 
 
Figure 5-13. Representative image of GFP-labelled cortical neuron. 
 
The mean number of GFP-labelled neurons examined per condition was 129 
(range 81-172). The mean maximum neurite outgrowth lengths of cortical 
neurons exposed to 10ng/ml or 100ng/ml of C5a, IL-6, IL-8 and TNF-a are 
shown in Table 5-1. 
 
 Mean maximum neurite 
outgrowth length, µm (SD) 
Control 279.0 (116.0) 
C5a  
 
10ng/ml 259.7 (115.8) 
100ng/ml 182.9 (63.3) 
IL-6  10ng/ml 284.9 (84.0) 
100ng/ml 239.1 (68.9) 
IL-8  
 
10ng/ml 177.2 (91.3) 
100ng/ml 210.6 (39.2) 
TNF-a 10ng/ml 229.6 (71.22) 
100ng/ml 303.0 (115.2) 
 











IL-8 was the only cytokine associated with reduced neurite length (Figure 5-
14). Mean difference between control and 10ng/ml was 0.357 (95% CI 0.063-




Figure 5-14. Fold change in mean neurite outgrowth length 





In an iPSC-derived cortical neuronal culture system, exposure to C5a was 
associated with increased neurogenesis, whilst exposure to IL-8 was 
associated with NPC proliferation and reduced neurite outgrowth. These 
findings were not observed with exposure to other pro-inflammatory 
cytokines suggesting that C5a and IL-8 may exert cell-specific effects to alter 
cortical neurogenesis. 
 
Complement C5a is a potent inflammatory mediator and a critical component 
of the innate immune response (Guo and Ward 2005) but accumulating 
evidence suggests that complement proteins are also involved in key 
biological processes of brain development and disorders of 
neurodevelopmental origin (Magdalon et al. 2020; Coulthard, Hawksworth, 
and Woodruff 2018). C5a acts via binding the G-protein coupled receptor 





























































































































































et al. 2001) and iPSCs (Hawksworth et al. 2014). In a mouse model of 
inflammation-induced preterm birth, C5a mediated glutamate excitotoxicity 
was found to contribute to cortical neuronal injury with C5aR blockade 
resulting in neuroprotection (Pedroni et al. 2014). Gene expression levels of 
C5a and the complement regulator SERPING 1 correlate with cortical 
thickness in humans (Allswede et al. 2018) and mouse embryos deficient in 
SERPING1 have reduced proliferation of intermediate progenitors, 
suggesting a role for the complement cascade in expansion of the neural 
progenitor pool in early cortical development (Gorelik et al. 2017). However, 
other studies have found that C5aR activation increased NPC proliferation 
through PKCζ/ERK signalling (Coulthard et al. 2017). 
 
IL-8 is a key mediator of the innate immune response and acts via 
chemokine receptors, CXCR1 and CXCR2. Both receptors bind IL-8 with 
similar affinity to activate growth and stress kinases such as ERK1/2, JNK1 
and p38, and induce intracellular calcium mobilisation from the endoplasmic 
reticulum to inhibit adenylyl cyclase and reduce AMP production. IL-8 has 
been shown to cause CXCR1-mediated death of NPCs (Kelland et al. 2011), 
whilst CXCR2 has been implicated in the maintenance of pluripotency and 
proliferation of human stem cells (Jung et al. 2015; Jiang et al. 2017). Pro-
inflammatory cytokines and chemokines in sufficient doses have previously 
been shown to have negative effects on neurite outgrowth (Matelski et al. 
2020). However, the mechanisms underlying this are not well understood. 
Neurite growth and guidance is regulated by multiple signalling pathways 
(Prem, Millonig, and DiCicco-Bloom 2020) involving extracellular factors 
(O'Kusky and Ye 2012), adhesion molecules (Jossin 2020; Miyamoto, 
Sakane, and Hashimoto 2015) and regulators of the cytoskeleton (Gallo 
2013) which may be influenced by exposure to inflammation. 
 
Wnt/ß-catenin signalling plays a key role in brain health and disease 
(Noelanders and Vleminckx 2017; Ng et al. 2019; Hoseth et al. 2018; Zhang, 




with preterm birth (Van Steenwinckel et al. 2019). Canonical Wnt signalling is 
associated with activation of inflammatory downstream pathways (Moparthi 
and Koch 2019), including IL-8 in the context of cancer (Wen et al. 2020) and 
neuroinflammation (Robinson, Narasipura, and Al-Harthi 2019). Wnt 
activation leads to the expansion of neural precursors whilst inhibition has 
been associated with premature cell cycle exit and a reduction in the 
precursor pool (Chenn and Walsh 2002; Woodhead et al. 2006; Zhou et al. 
2006; Srikanth et al. 2015). 
 
Another pathway to consider is the interaction between mitochondrial 
metabolism and innate immunity, which has been recognised in the context 
of neuroinflammation and psychiatric disease (Culmsee et al. 2019). 
Exposure to pro-inflammatory proteins may influence mitochondrial functions 
which are fundamental to neurogenesis. The metabolic switch from glycolytic 
metabolism to oxidative phosphorylation appears to be an important regulator 
of stem cell commitment (Khacho and Slack 2018) and altered mitochondrial 
dynamics have been associated with defects in cell cycle exit, impaired 
neurite outgrowth (Nguyen et al. 2018) and cortical maldevelopment (Khacho 
et al. 2017).  
 
Strengths of this study include: (1) the selection of biologically relevant 
concentrations of inflammation-associated proteins known to be differentially 
expressed in preterm infants when compared to term-born controls 
(Boardman et al. 2018) and elevated in the context of histologic 
chorioamnionitis (Hecht et al. 2011), FIRS (Costa and Castelo 2016) and 
neuroinflammation (Lee, Nagai, and Kim 2002), (2) the use of an established 
human culture system of an enriched neuronal population which is 
biologically relevant for the study of fetal and early postnatal cortical 
development, and (3) the principled selection of outcome measures based on 
established observations of reduced volume and altered cortical 
microstructure in preterm infants at term-equivalent age and the proposed 




A limitation of the study is that the culture system did not allow the analysis of 
interneurons, which comprise 20% of the human cerebral cortex (Wonders 
and Anderson 2006). Inflammation has been associated with disrupted 
interneuron maturation in animal models and human preterm infants (Stolp et 
al. 2019) and culture systems to integrate both excitatory and inhibitory 
neuron populations may be important when modelling cortical injury, as Nitric 
oxide synthase expressing interneurons play a major role in neuronal death 
in response to cytotoxicity or ischaemia (Xu et al. 2016).  
 
Whilst there were no significant changes in mean nuclei number observed 
under experimental conditions, no assessment of cell health/death assays 
were performed. Cell death is a recognised feature of brain injury associated 
with inflammation and molecular mechanisms should be considered in future 
study designs (Galluzzi et al. 2018; Truttmann, Ginet, and Puyal 2020). 
 
Another limitation is that we could not investigate sex-specific effects as 
iPSCs were generated from a healthy female control. Environmental effects 
on brain development and immune function after preterm birth may be sex-
specific (O'Driscoll et al. 2018; O'Driscoll, Greene, and Molloy 2017; 
Hanamsagar et al. 2017; Makinson et al. 2017), and long-term impact on 
brain growth has been described (Reiss et al. 2004; Kesler et al. 2008).  
 
Enriched monolayer systems can provide valuable information about cell-
specific effects but there are limitations to the use of 2D cultures which do not 
recapitulate the complexity and organisation of human brain development. 
The cell density is invariably lower than in vivo and the architecture and 
microenvironment are different. Given the fundamental role of glia in 
amplification of the neuroinflammatory response, organoid culture systems 
incorporating both astrocytes and microglia offer the most comprehensive 
model of early human brain development. Future work investigating the 




interrogation of cellular targets linking systemic inflammation with altered 
cortical development.  
 
5.5 Conclusions 
These data demonstrate that clinically relevant doses of complement protein 
C5a and IL-8 are capable of influencing cell type diversity and neurite 
outgrowth in the developing neocortex. Whether these observations have 
functional consequences in vivo is yet to be determined and further work to 
identify the molecular and cellular mechanisms regulating proliferation and 
differentiation of radial glia and intermediate progenitors would provide 
important insights (Beattie and Hippenmeyer 2017).   
As the sequential nature of progenitor diversification is critical to ensure 
optimal layering, organisation and efficient network formation within the 
cerebral cortex, these findings suggest that inflammation is implicated in the 
aetiology of cortical dysmaturation associated with preterm birth, focussing 































6.1 Summary of findings 
Despite considerable improvements in survival rates after preterm birth, 
infants remain at high risk of brain injury and a range of adverse lifecourse 
outcomes. Whilst the role of inflammation in the encephalopathy of 
prematurity is well described, there are no therapeutic strategies available to 
reduce the risk of impairment. 
The primary aim of this thesis was to identify specific immune mediators 
associated with atypical brain development after preterm birth to elucidate 
new targets for neuroprotective therapies. The integrated analysis of 
placenta, blood and brain MRI with human stem cell technology generated 
several key findings: 
 
• Preterm infants have a distinct pro-inflammatory profile in umbilical 
cord blood when compared to term-born controls. 
• Exposure to histologic chorioamnionitis was associated with 
alterations in the expression of several innate immune mediators in 
the umbilical cord blood of preterm infants but IL-8 proved to be the 
best predictor.  
• Preterm infants who were exposed to histologic chorioamnionitis had 
an altered blood immune profile on postnatal day 5, suggesting that 
the systemic inflammatory response to intrauterine inflammation is 
sustained beyond delivery. 
• Day 5 IL-8 concentration was associated with white matter 
microstructure, characterised by PSNDI, in preterm infants at term-
equivalent age. 
• In an iPSC-derived platform of cortical neurogenesis, complement 
protein C5a was associated with neuronal maturation, whilst IL-8 was 






As the histopathological diagnosis of chorioamnionitis is often delayed 
beyond the time of delivery, IL-8 offers a promising blood-based biomarker to 
identify exposure to intrauterine inflammation and activation of the neonatal 
systemic inflammatory response. Several studies have also shown that IL-8 
is predictive of neonatal sepsis (Leviton et al. 2012; Zhou et al. 2015; Wong 
et al. 2008) and necrotising enterocolitis (Maheshwari et al. 2014; Benkoe et 
al. 2014). A chip-based immunoaffinity capillary electrophoresis (ICE) system 
has now been developed for measuring inflammatory mediators in dried 
blood spots with comparable accuracy to conventional immunoassays and 
could be utilised to quantify IL-8 at the cotside using small volume samples 
(Guzman and Guzman 2016; Phillips 2018). The coupling of highly selective 
antibody-capture with the resolution of capillary electrophoresis offers rapid, 
sensitive and cost-effective point of care testing with the potential to inform 
clinical decision making in the neonatal unit.  
Given that FIRS is associated with increased risks of subsequent lung 
disease, bloodstream infection, and brain injury, it may be that infants who 
present with systemic inflammation and elevated IL-8 on admission to the 
neonatal unit require an individualised approach to reduce the risk of further 
inflammatory complications.  
 
Previous studies investigating the relationship between immune mediators 
and brain imaging outcomes were limited to the identification of acquired 
brain lesions using cranial ultrasound and structural MRI. Through the use of 
diffusion MRI to characterise white matter development after preterm birth, 
Chapter 4 indicates that IL-8 may link systemic inflammation and white 
matter dysmaturation in preterm infants. IL-8 concentration on postnatal day 
5 was associated with white matter microstructure characterised by PSNDI at 
term-equivalent age. This association may describe a relationship between 
the severity of systemic inflammation and white matter dysmaturation or 
highlight a specific role of IL-8. There are multiple potential mechanisms 
through which IL-8 dysregulation may disrupt healthy brain development but 




important given the intricacy of immune responses. Individual mediators 
rarely function in isolation, instead contributing multiple roles within a 
complex system of cytokine networks. 
 
The cellular composition and cytoarchitecture of the developing cerebral 
cortex are dependent upon proliferative expansion of the progenitor pool 
followed by a carefully timed switch to neurogenesis through a diverse array 
of progenitor subtypes including radial glia and intermediate progenitors. 
Mathematical modelling of cortical development suggests that altered 
progenitor output potential at different stages of fate determination could 
have major impact on cortical size and structural connectivity (Picco et al. 
2018; Postel et al. 2019). Using a human iPSC-derived system to study 
cortical development, C5a was shown to influence the generation of 
excitatory glutamatergic neurons, whilst IL-8 was associated with increased 
progenitor proliferation and altered neurite outgrowth, suggesting that 
immune mediators associated with the systemic inflammatory response may 
exert cell-specific effects in the developing neocortex.  
The discovery of altered neurite length associated with exposure to IL-8 may 
represent poor neuronal health, dysmaturation or a structural deficit. Given 
the importance of neurite outgrowth for dendritic arborisation, synaptogenesis 
and axonal guidance, future studies to identify the potential mechanisms and 
functional significance of this finding are warranted.  
 
 
6.2 Strengths and limitations  
This is the first study to integrate information about systemic inflammation 
from placenta and blood with biomarkers of white matter microstructure in 
preterm infants. The preterm birth cohort studied was representative of a 
typical preterm population in terms of antenatal factors and neonatal 
morbidity. An unbiased data driven approach to biomarker discovery was 
used and an imaging protocol using multi-shell acquisitions with high b-




Peak width skeletonised water diffusion parameters were used as biomarkers 
of generalised white matter connectivity in view of their utility in discriminating 
preterm infants from term-born controls at term-equivalent age (Blesa et al. 
2020). This thesis also demonstrates the utility of these metrics to investigate 
the impact of perinatal exposures on neonatal brain tissue development and 
their use in other neonatal populations at risk of altered brain development 
should be evaluated.  
Histogram-based analyses of DTI and NODDI are computationally 
inexpensive and can be applied to combine data acquired from different 
scanners facilitating their potential application as biomarkers in future clinical 
trials of neuroprotection. 
Whilst PSMD has been associated with processing speed and cognitive 
ability in adults (Deary et al. 2019; Wei et al. 2019), it will be important to 
assess long-term outcomes in order to characterise the neurodevelopmental 
correlates and predictive performance of PSMD and PSNDI in children who 
were born preterm.  
 
A limitation of the work presented in this thesis is that maternal immune 
influences and risk or resilience conferred by the genome or epigenome were 
not able to be examined. Studies investigating the maternal immune 
activation hypothesis have shown that maternal inflammation is associated 
with offspring brain development (Rudolph et al. 2018; Wu et al. 2017; Al-
Haddad et al. 2019; Estes and McAllister 2016). Placental signalling also 
plays a role in neurodevelopmental programming through altered gene 
expression and epigenetic responses to fetal and maternal environmental 
signals (Shallie and Naicker 2019).  
 
Prematurity may represent an environmental influence which exposes 
underlying genetic susceptibility to brain injury resulting from 
neuroinflammation. Genome-wide association studies have identified variants 
associated with prematurity (Zhang et al. 2017) and genetic susceptibility to 
brain injury after preterm birth has been described (Boardman et al. 2014; 




Wang, et al. 2017). Dynamic epigenetic mechanisms including DNA 
methylation, histone modifications, chromatin remodelling and non-coding 
RNAs are involved in the regulation of gene expression during 
neurodevelopment (Spiers et al. 2015) and the co-ordination of innate 
immune responses (Zhang and Cao 2019). These processes can be 
influenced by early exposure to the extrauterine environment and altered in 
the context of perinatal brain injury (Sparrow et al. 2016; Provenzi, Guida, 
and Montirosso 2018; Everson et al. 2019; O'Sullivan et al. 2019).  
 
Another limitation is that sample size did not permit sub-group analyses 
based on gestational age or sex. There is an increased risk of fetal 
inflammation with lower gestational age and many of the complications of 
prematurity are encountered more frequently in infants at the threshold of 
viability. This may be explained by immune dysregulation or may simply 
reflect increased vulnerability of developing organ systems. Environmental 
effects on brain development and immune function may be sex-specific, 
particularly given the role of microglia as both targets and drivers of brain 
sexual differentiation (O'Driscoll et al. 2018; O'Driscoll, Greene, and Molloy 
2017; Hanamsagar et al. 2017; Makinson et al. 2017).  
 
 
6.3 Future directions 
The development of therapeutic strategies targeting inflammation in preterm 
brain injury has been hindered by difficulties in accessing primary brain tissue 
and a failure of animal models to fully recapitulate human neurobiology. 3D 
organoids offer an exciting tool to study human brain development, 
particularly dynamic functions such as neuronal migration and cortical 
layering (Lancaster et al. 2013). Organoids with a mixed culture of 
neuroectoderm, microglia and endothelial vascular cells offer a more 
representative model of early human brain development with the added 
ability to interrogate the role of crosstalk between neurons and glia in the 




Muffat, Li, and Jaenisch 2016; Madhavan et al. 2018). Bioengineering 
techniques may also provide additional opportunities to enhance organoid 
culture systems using microfluidic channels to control the microenvironment 
(Lovett et al. 2020) . 
3D cortical organoids follow the pace of human fetal brain development 
(Paşca et al. 2015) and have been utilised to study neonatal brain injury in 
the context of hypoxia-ischaemia (Boisvert et al. 2019; Pașca et al. 2019).  
An organoid platform relevant to early fetal neurodevelopment will enable the 
study of both environmental and genetic factors underlying preterm brain 
injury with reproducibility and scalability, both of which are key to developing 
high throughput drug screening models (Yoon et al. 2019; Velasco et al. 
2019).  
 
This thesis focusses attention on the role of complement and IL-8 in linking 
systemic inflammation with preterm brain dysmaturation. Given the complex 
role of the immune system in key processes of neurodevelopment, further 
understanding of the underlying molecular and cellular mechanisms 
alongside studies of the functional consequences of the phenotypes 
observed are key next steps to exploring their potential as targets for 
immunomodulation. It will also be important to validate these observations 
with a replication cohort, ideally complemented by transcriptional profiling. 
Previous pathway analyses using whole blood RNA showed a distinct 
immune metabolic signature of neonatal infection (Smith, Dickinson, et al. 
2014) but fetal inflammatory responses have not yet been fully characterised.  
 
Given the role of inflammation in white matter dysmaturation, another exciting 
area of future development is the refinement of myelin imaging techniques for 
neonatal application. The Theirworld Edinburgh Birth Cohort imaging protocol 
was recently extended to include a magnetisation transfer ratio (MTR) with 
successful acquisition of images from preterm infants and term-born controls. 
Using the ratio between free water and water with restricted motion due to 




developing brain with potential for future application in studying the impact of 
perinatal exposures such as inflammation and nutrition.  
 
The emerging field of immunoneuropsychiatry recognises the importance of 
early life inflammatory exposures on immune programming and brain health 
across the lifecourse (Pape et al. 2019; Al-Haddad et al. 2019; Rychlik and 
Sillé 2019) and the long-term follow up of babies in this cohort will facilitate 
knowledge discovery in this area. Thorough the combination of standardised 
developmental assessments, linkage to routinely collected datasets and 
longitudinal MRI brain scans in childhood and adolescence, there will be an 
opportunity to characterise early neural and immune signatures of later 
psychiatric disease associated with preterm birth.  
 
The quest to find reliable imaging and blood-based biomarkers predictive of 
long-term outcomes remains a challenge within neonatal medicine, but it is 
likely that a multiparametric approach will be required to enable early 
identification of infants at risk who could benefit from targeted intervention.  
Combining organoid technology with the power of -omics approaches may 
facilitate the discovery of specific factors associated with risk or resilience to 
inflammation and brain injury. In the future, iPSCs could be produced from 
somatic cells of participants and used to generate organoids to interrogate 
neuropathology, elucidate cellular targets and test potential therapies, 
offering the possibility of truly individualised precision medicine. 
 
Cohort retention is crucial to the realisation of these objectives and creative 
solutions to maintaining participant engagement during a global pandemic 






This thesis contributes three studies which provide novel insights into the role  
of inflammation in the aetiology of cortical dysmaturation and altered white 
matter microstructure associated with preterm birth. There appears to be a 
window of opportunity for therapeutic intervention using anti-inflammatory or 
immunomodulatory therapies after preterm birth and future work should focus 
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